| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size | Unit | MAT Value as on 30th Sept. 2013 | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | 6.2.1.8.1 | Cloxacillin Capsule 250 mg | BIOCLOX 250 MG CAPSUL | -- | BIOCHEM PHARMACEUTICAL INDS | 250 mg | 10 | Capsule | 711532 | 58.64% | 10.20 | 1.02 | -- |
| -- | -- | -- | CLX 250 MG CAPSULE 10 | -- | PSYCHOTROPICS INDIA LTD | 250 mg | 10 | Capsule | 272883 | 22.49% | 10.50 | 1.05 | -- |
| -- | -- | -- | KLOX 250 MG CAPSULE 15 | -- | HETERO HEALTHCARE LTD | 250 mg | 15 | Capsule | 228935 | 18.87% | 15.75 | 1.05 | -- |
| -- |
-- |
-- |
-- |
1213350 | 100.00% | -- | 1.04 | 1.21 | |||||
| -- | -- | -- |
-- |
-- |
-- |
-- | Maximum | 1.05 | Minimum | 1.02 | |||
| -- | -- | -- | As per the above there are 3 companies consisting of Market Share of 1% & Above | -- | -- | -- |
-- |
-- | -- | ||||
| -- | -- | -- | Sum of MAT value considered for price calculation | -- | -- | 12.13 | (Rs. in Lakhs) |
-- |
-- | -- | |||
| -- | -- | -- | Sum of PTR per unit considered for price calculation | -- | -- | 3.12 | -- | -- |
-- |
-- | -- | ||
| -- | -- | -- | Number of Packs considered | -- | -- | 3 | -- | -- |
-- |
-- | -- | ||
| -- | -- | -- | Average PTR | -- | -- | -- | 1.04 | -- | -- |
-- |
-- | -- | |
| -- | -- | -- | Add : 16% Retailer Margin | -- | -- | -- | 0.17 | -- | -- |
-- |
-- | -- | |
| -- | -- | -- | Ceiling Price (without local taxes) | -- | -- | 1.21 | -- | -- |
-- |
-- | -- | ||
| -- | -- | -- | % Reduction with compared to Highest Price | -- | -- | 0.95% | -- | -- |
-- |
-- | -- | ||
| -- | -- | -- | WPI factor @ 6.32% | -- | -- | -- | 0.08 |
-- |
-- | -- | |||
| -- | -- | -- | Revised Ceiling Price (including WPI but without local taxes) |
-- | -- | -- | 1.29 | S.O. 3127(E) dated 10.12.2014 | |||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size | Unit | MAT Value as on 30th Sept. 2013 | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 12.3.0.10 | Methyldopa Tablets 250 mg | ALPHADOPA FILM C.TABS 250 MG x 10 | ALPHADOPA | WOCKHARDT LTD | 250 mg | 10 | TABS | 125341860 | 99.95% | 17.67 | 1.77 | -- |
| -- | -- | Methyldopa Tablets 250 mg | GYNAPRES 250 MG TABLET 1 | GYNAPRES | MANKIND PHARMA | 250 mg | 10 | TABS | 66420 | 0.05% | 18.36 | 1.84 | -- |
| -- | -- | Methyldopa Tablets 250 mg | MEDOPRES FILM C.TABS 250 MG x 10 | -- | EAST WEST PHAR | 250 mg | 10 | TABS | 1,095 | 0.00% | 15.00 | 1.50 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | 125,409,375 | 100.00% | Average | 1.77 | -- |
| -- | -- | Monopoly situation as M/s WOCKHARDT LTD is the company manufacturing the formulation and has market share of 99.92% |
-- |
-- |
-- |
-- |
|||||||
| -- | -- | PTR per unit | -- | 1.77 |
-- |
-- |
-- |
-- |
|||||
| -- | -- | Price fixed in the relevant sub-section for other drugs is as follows: |
-- |
-- |
-- |
-- |
|||||||
| -- | -- | 12.3: Antihypertensive medicines |
-- |
||||||||||
| -- | -- | Medicines | Category | Route of Admn | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No | Date | % Reduction w.r.t. Highest Price |
-- |
||
| -- | -- | Amlodipine | P,S,T | Tablets | 2.5 mg | 1.79 | 10th | 3772 | 20.12.2013 | 53.19% | -- |
-- |
|
| -- | -- | Amlodipine | P,S,T | Tablets | 5 mg | 2.83 | 10th | 3773 | 20.12.2013 | 62.23% | -- |
-- |
|
| -- | -- | Atenolol | P,S,T | Tablets | 50 mg | 2.07 | 2nd | 1810 | 21.06.2013 | 44.14% | -- |
-- |
|
| -- | -- | Atenolol | P,S,T | Tablets | 100 mg | 3.72 | 1st | 1632 | 14.06.2013 | 24.17% | -- |
-- |
|
| -- | -- | Enalapril Maleate | P,S,T | Tablets | 2.5 mg | 1.78 | 1st | 1633 | 14.6.2013 | 6.75% | -- |
-- |
|
| -- | -- | Enalapril Maleate | P,S,T | Tablets | 5mg | 2.96 | 1st | 1634 | 14.6.2013 | 14.33% | -- |
-- |
|
| -- | -- | Enalapril Maleate | T | Injection | 1.25mg/ml | 174.20 | 18th | 2357 | 15.09.2014 | 10.54% | -- |
-- |
|
| -- | -- | Losartan Potassium | S, T | Tablets | 25 mg | 2.50 | 1st | 1635 | 14.6.2013 | 31.57% | -- |
-- |
|
| -- | -- | Losartan Potassium | S, T | Tablets | 50 mg | 4.30 | 1st | 1636 | 14.6.2013 | 33.80% | -- |
-- |
|
| -- | -- | Methyldopa | P,S, T | Tablets | 250 mg | Under consideration | -- | -- | -- | -- | -- |
-- |
|
| -- | -- | Nifedipine | S, T | Capsules | 5 mg | 0.86 | 3rd | 1900 | 28.06.2013 | 6.44% | -- |
-- |
|
| -- | -- | Nifedipine | S, T | Capsules | 10mg | 1.18 | 1st | 1637 | 14.6.2013 | 12.90% | -- |
-- |
|
| -- | -- | Nifedipine | S, T | Tablets | 10mg | 1.13 | 1st | 1638 | 14.6.2013 | 16.96% | -- |
-- |
|
| -- | -- | Nifedipine | S, T | Tablets | 20mg | 0.32 | 9th | 3563 | 02.12.2013 | 15.52% | -- |
-- |
|
| -- | -- | Nifedipine | S, T | Sustained Release Tablets | 10mg | 1.42 | 3rd | 1901 | 28.06.2013 | 16.79% | -- |
-- |
|
| -- | -- | Nifedipine | S, T | Sustained Release Tablets | 20mg | 1.90 | 4th | 2061 | 05.07.2013 | 24.51% | -- |
-- |
|
| -- | -- | Nifedipine | S, T | Sustained Release Capsules | 10mg | 1.67 | 7th | 2844 | 20.09.2013 | 15.52% | -- |
-- |
|
| -- | -- | Nifedipine | S, T | Sustained Release Capsules | 20mg | 2.19 | 7th | 2845 | 20.09.2013 | 15.52% | -- |
-- |
|
| -- | -- | Sodium Nitroprusside | T | Injection | 50 mg/ 5 ml | 129.98 | 3rd | 1902 | 28.06.2013 | 4.82% | -- |
-- |
|
| -- | -- | Added Medicines | -- |
-- |
|||||||||
| -- | -- | Hydrochlorthiazide | P,S,T | Tablets | 12.5 mg | 0.97 | 1st | 1639 | 14.6.2013 | 22.13% |
-- |
-- | |
| -- | -- | Hydrochlorthiazide | P,S,T | Tablets | 25 mg | 1.66 | 1st | 1640 | 14.6.2013 | 20.78% |
-- |
-- | |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
-- |
-- | |
| -- | -- | -- | -- | -- | -- | -- | -- | Average Re | -- | 22.63% |
-- |
-- | |
| -- | -- | Therefore, PTR per unit | 1.77 X (1-22.63%) | 1.37 |
-- |
-- |
-- |
-- | |||||
| -- | -- | Add: 16% Retailer Margin | -- | 0.22 |
-- |
-- |
-- |
-- | |||||
| -- | -- | Ceiling Price per unit | -- | 1.59 |
-- |
-- |
-- |
-- | |||||
| -- | -- | WPI factor @ 6.32% | -- | 0.10 |
-- |
-- |
-- |
-- | |||||
| -- | -- | Revised Ceiling Price (including WPI but without local taxes) |
-- | 1.69 | S.O. 3129(E) dated 10.12.2014 | -- | -- | -- |
-- |
-- | -- | ||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size | Unit | MAT Value as on 31st May, 2012 | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 12.1.0.4.2.2 | Isosorbide Dinitrate | Sorbitrate 20 Mg Tablet 10 | -- | Abbott Healthcare Pvt | 20 mg | 10 | Tablet | 82601 | 61.41% | 33.15 | 3.31 | -- |
| -- | -- | -- | Sorbitrate 20 Mg Tablet 50 | -- | Abbott Healthcare Pvt | 20 mg | 50 | Tablet | 51906 | 38.59% | 56.79 | 1.14 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | 134507 | -- | Average reduction | 2.23 | -- |
| -- | -- | Monopoly situation as M/s Abbott. is the company manufacturing the formulation and has market share of 100% |
-- |
-- | -- |
-- |
-- | ||||||
| -- | -- | PTR per unit | -- | -- |
-- |
-- | |||||||
| -- | -- | Price fixed in the relevant sub-section for other drugs is as follows: | 2.23 |
-- |
-- | ||||||||
| -- |
-- |
12.1: Antianginal medicines |
-- |
-- | |||||||||
| -- | -- | Medicines | Category | Route of Admn | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No | Date | % Reduction w.r.t. Highest Price |
-- |
-- | |
| -- | -- | Isosorbide 5 Mononitrate | P,S,T | Tablets | 10 mg | 1.92 | 1st | 1625 | 14.06.2013 | 29.73% |
-- |
-- | |
| -- | -- | Isosorbide 5 Mononitrate | P,S,T | Tablets | 20 mg | 3.29 | 1st | 1626 | 14.06.2013 | 33.22% |
-- |
-- | |
|
-- |
Isosorbide Dinitrate | P,S,T | Tablets | 10 mg | 0.69 | 4th | 2057 | 05.07.2013 | 18.63% |
-- |
|||
|
-- |
-- |
-- |
Average Reduction | 27.19% |
-- |
||||||||
|
-- |
Therefore, PTR per unit | 2.23 X (1-27.19%) | 1.62 | -- |
-- |
||||||||
|
-- |
Add: 16% Retailer Margin | -- | 0.26 | -- |
-- |
||||||||
|
-- |
Ceiling Price per unit | -- | 1.88 | -- |
-- |
||||||||
|
-- |
WPI factor @ 6.32% | -- | 0.12 | -- |
-- |
||||||||
|
-- |
Revised Ceiling Price (including WPI but without local taxes) |
-- | 2.00 | S.O. 3128(E) dated 10.12.2014 |
-- |
||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size | Unit | MAT Value as on 31st May, 2012 | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 1.1.4.1 | Ketamine Hydrochloride | ANEKET 10 MG INJECTION | ANEKET | NEON LABORATO | 10 mg/ml | 10 | Injection | 1729849 | 77.61% | 87.00 | 8.70 | -- |
| -- | -- | -- | KETMIN 10 MG INJECTION | KETMIN | THEMIS MEDICAR | 10 mg/ml | 10 | Injection | 498996 | 22.39% | 83.81 | 8.38 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | 2228845 | 100.00% | -- | 8.54 | 9.91 |
| -- | -- |
-- |
-- |
-- |
-- | Maximum | 8.70 | Minimum | 8.38 | ||||
| -- | -- | -- | As per the above there are 2 companies consisting of Market Share of 1% & Above | -- | -- | -- | -- | -- | -- | -- | |||
| -- | -- | -- | Sum of MAT value considered for price calculation | -- | -- | 22.29 | (Rs. in Lakhs) | -- | -- | -- | -- | ||
| -- | -- | -- | Sum of PTR per unit considered for price calculation | -- | -- | 17.08 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | Number of Packs considered | -- | -- | 2 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | Average PTR | -- | -- | -- | 8.54 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Add : 16% Retailer Margin | -- | -- | -- | 1.37 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Ceiling Price (without local taxes) | -- | -- | 9.91 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | % Reduction with compared to Highest Price | -- | -- | 1.84% | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | WPI factor @ 6.32% | -- | -- | -- | 0.63 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Revised Ceiling Price (including WPI but without local taxes) |
-- | -- | -- | 10.54 | S.O. 3126(E) dated 10.12.2014 | -- | -- | -- | ||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size | Unit | MAT Value as Sept. 2013 | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.2.2.7.1 | Gentamicin Injection 10 mg / ml | GENTICYN PEAD 10 MG INJECTION 2 ML | -- | ABBOTT HEALTHCA | 10 mg/ml | 2 | Injection | 7413291 | 88.96% | 5.04 | 2.52 | -- |
| -- | -- | -- | Genticin Inj Vial 10 mg 2 ml x 1 | -- | ABBOTT HEALTHCA | 10 mg/ml | 2 | Injection | 22103 | 0.27% | 5.28 | 2.64 | -- |
| -- | -- | Gentamicin Injection 10 mg / ml | GRACIN 10 MG INJECTION 10 ML | GRACIN | BIOCHEM PHARMACEUTICAL INDS | 10 mg/ml | 10 | Injection | 213266 | 2.56% | 26.40 | 2.64 | -- |
| -- | -- | Gentamicin Injection 10 mg / ml | LYRAMYCIN INJ VIAL PED | LYRAMYCIN | HETERO HEALTHCA | 10 mg/ml | 2 | Injection | 17,363 | 0.21% | 5.00 | 2.50 | -- |
| -- | -- | Gentamicin Injection 10 mg / ml | MERIGENTA INJ VIAL 10 M | MERIGENTA | MERCURY LABS | 10 mg/ml | 2 | Injection | 32,107 | 0.39% | 5.28 | 2.64 | -- |
| -- | -- | Gentamicin Injection 10 mg / ml | MERIGENTA INJ AMP 10 M | MERIGENTA | MERCURY LABS | 10 mg/ml | 2 | Injection | 31,692 | 0.38% | 5.00 | 2.50 | -- |
| -- | -- | Gentamicin Injection 10 mg / ml | ZENOTIC INJ AMP 10 MG 2 | ZENOTIC | PLETHICO | 10 mg/ml | 2 | Injection | 30,490 | 0.37% | 5.28 | 2.64 | -- |
| -- | -- | Gentamicin Injection 10 mg / ml | GENSTER INJ VIAL 10 MG 2 | GENSTER | STERKEM | 10 mg/ml | 2 | Injection | 573,299 | 6.88% | 5.00 | 2.50 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | 8333610 | 100.00% | -- | 2.58 | 2.99 |
| -- | -- |
-- |
-- |
-- |
-- | Maximum | 2.64 | Minimum | 2.50 | ||||
| -- | -- | -- | As per the above there are 2 companies consisting of Market Share of 1% & Above | -- | -- | -- | -- | -- | -- | -- | |||
| -- | -- | -- | Sum of MAT value considered for price calculation | -- | -- | 82.22 | (Rs. In Lakh) | -- | -- | -- | -- | ||
| -- | -- | -- | Sum of PTR per unit considered for price calculation | -- | -- | 10.30 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | Number of Packs considered | -- | -- | 4 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | Average PTR | -- | -- | -- | 2.58 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Add : 16% Retailer Margin | -- | -- | -- | 0.41 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Ceiling Price (without local taxes) | -- | -- | 2.99 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | % Reduction with compared to Highest Price | -- | -- | 2.27% | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | WPI factor @ 6.32% | -- | -- | -- | 0.19 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Revised Ceiling Price (including WPI but without local taxes) |
-- | -- | -- | 3.18 | S.O. 3127(E) dated 10.12.2014 | -- | -- | -- | ||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size | Unit | MAT Value as Sept. 2013 | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 26.2.0.3 | Sodium Chloride Injection 0.9% or Normal Saline | -- | -- | Ahlcon Parenterals (India) Ltd. | 500 Ml | 500 | Injection | 86636214 | 3.19% | 20.33 | 0.04 | -- |
| -- | -- | -- | -- | -- | Ahlcon Parenterals (India) Ltd. | 100 Ml | 100 | Injection | 16587811 | 0.61% | 11.47 | 0.11 | -- |
| -- | -- | -- | -- | -- | B Barun Medical (India) Pvt. Ltd. | 500 Ml | 500 | Injection | 73872613 | 2.72% | 20.33 | 0.04 | -- |
| -- | -- | -- | -- | -- | B Barun Medical (India) Pvt. Ltd. | 100 Ml | 100 | Injection | 11011567 | 0.41% | 11.47 | 0.11 | -- |
| -- | -- | -- | PVC Bag with two ports one port for extramedication and other for infusion | -- | Baxter(India) Pvt. Ltd. | 500 Ml | 500 | Injection | 120054543 | 4.43% | 20.00 | 0.04 | -- |
| -- | -- | -- | PVC Bag with two ports one port for extramedication and other for infusion | -- | Baxter(India) Pvt. Ltd. | 100 Ml | 100 | Injection | 71290149 | 2.63% | 12.00 | 0.12 | -- |
| -- | -- | Sodium Chloride Injection 0.9% or Normal Saline | Plastic Bottles Nipple Head | -- | Baxter(India) Pvt. Ltd. | 500 Ml | 500 | Injection | 260716833 | 9.61% | 18.02 | 0.04 | -- |
| -- | -- | -- | -- | -- | Baxter(India) Pvt. Ltd. | 100 Ml | 100 | Injection | 38805242 | 1.43% | 9.74 | 0.10 | -- |
| -- | -- | -- | Nipple Head- Plastic | -- | Amanta Healthcare Limited | 100 Ml | 100 | Injection | 15220423 | 0.56% | 12.30 | 0.12 | -- |
| -- | -- | -- | -- | -- | Amanta Healthcare Limited | 250 ML | 250 | Injection | 111236 | 0.00% | 15.41 | 0.06 | -- |
| -- | -- | -- | -- | -- | Amanta Healthcare Limited | 500 ML | 500 | Injection | 77679416 | 2.86% | 21.80 | 0.04 | -- |
| -- | -- | -- | -- | -- | Amanta Healthcare Limited | 1000 ML | 1000 | Injection | 14219336 | 0.52% | 30.00 | 0.03 | -- |
| -- | -- | -- | -- | -- | Hindustan Antibiotics Ltd. | 500 ML | 500 | Injection | 2394304 | 0.09% | 16.85 | 0.03 | -- |
| -- | -- | -- | Each 100 ml contains: Sodium ChlorideIP: 900 mg water for Injection Ip |
-- | Parenteral Drugs (India) Ltd. | 500 ML | 500 | Injection | 120611433 | 4.45% | 18.35 | 0.04 | -- |
| -- | -- | -- | -- | -- | Parenteral Drugs (India) Ltd. | 1000 ML | 1000 | Injection | 52177800 | 1.92% | 30.69 | 0.03 | -- |
| -- | -- | -- | -- | -- | Parenteral Drugs (India) Ltd. | 100 ML | 100 | Injection | 10386097 | 0.38% | 10.32 | 0.10 | -- |
| -- | -- | -- | Each 100 ml contains: Sodium ChlorideIP: 0.9 mg water for Injection IP (Plastic FFS Bottle) |
-- | Nirma Limited | 100 ML | 100 | Injection | 102026425 | 3.76% | 11.34 | 0.11 | -- |
| -- | -- | -- | -- | -- | Nirma Limited | 250 ML | 250 | Injection | 8698058 | 0.32% | 15.26 | 0.06 | -- |
| -- | -- | -- | -- | -- | Nirma Limited | 500 Ml | 500 | Injection | 431855684 | 15.93% | 20.11 | 0.04 | -- |
| -- | -- | -- | -- | -- | Nirma Limited | 1000 ML | 1000 | Injection | 143097024 | 5.28% | 33.59 | 0.03 | -- |
| -- | -- | -- | -- | -- | Nirma Limited | Glass bottle 100 ML | 100 | Injection | 18265062 | 0.67% | 12.59 | 0.13 | -- |
| -- | -- | -- | Plastic Bottle | -- | Fresenius Kabi India Pvt. Ltd | 100 Ml | 100 | Injection | 47761895 | 1.76% | 11.58 | 0.12 | -- |
| -- | -- | -- | -- | -- | Fresenius Kabi India Pvt. Ltd | 1000 ML | 1000 | Injection | 63446832 | 2.34% | 34.28 | 0.03 | -- |
| -- | -- | -- | -- | -- | Fresenius Kabi India Pvt. Ltd | 500 Ml | 500 | Injection | 130165463 | 4.80% | 20.51 | 0.04 | -- |
| -- | -- | Freeflex Normal Saline 0.9% | Freeflex Bag (Non PVC Bag made of Polyolefin with ports) |
-- | Fresenius Kabi India Pvt. Ltd | 100 Ml | 100 | Injection | 92285887 | 3.40% | 12.00 | 0.12 | -- |
| -- | -- | -- | Freeflex Bag (Non PVC Bag made of Polyolefin with ports) |
-- | Fresenius Kabi India Pvt. Ltd | 500 ML | 500 | Injection | 50113522 | 1.85% | 20.00 | 0.04 | -- |
| -- | -- | -- | Poly | -- | Albert David Limited | 500 ML | 500 | Injection | 113747902 | 4.19% | 19.43 | 0.04 | -- |
| -- | -- | -- | Glass | -- | Albert David Limited | 500 ML | 500 | Injection | 17370520 | 0.64% | 22.78 | 0.05 | -- |
| -- | -- | -- | Nipple Head Plastic Bottle | -- | Claris Lifesciences Limited | 100 ML | 100 | Injection | 74093918 | 2.73% | 12.23 | 0.12 | -- |
| -- | -- | -- | Nipple Head Plastic Bottle | -- | Claris Lifesciences Limited | 250 ML | 250 | Injection | 1493423 | 0.06% | 15.00 | 0.06 | -- |
| -- | -- | -- | Nipple Head Plastic Bottle | -- | Claris Lifesciences Limited | 500 Ml | 500 | Injection | 232845961 | 8.59% | 21.68 | 0.04 | -- |
| -- | -- | -- | Nipple Head Plastic Bottle | -- | Claris Lifesciences Limited | 1000 ML | 1000 | Injection | 89260893 | 3.29% | 30.00 | 0.03 | -- |
| -- | -- | -- | Non PVC Bag | -- | Claris Lifesciences Limited | 500 Ml | 500 | Injection | 42652651 | 1.57% | 54.28 | 0.11 | -- |
| -- | -- | -- | -- | -- | IVES Drugs(India) Pvt. Ltd. | 500 Ml | 500 | Injection | 7104888 | 0.26% | 20.00 | 0.04 | -- |
| -- | -- | -- | Each 100 ml contains: Sodium ChlorideIP: 0.9% gm water for Injection Ip 100 ml |
-- | Wockhardt Limited | 100 ML | 100 | Injection | 73625885 | 2.72% | 10.66 | 0.11 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | ######### | 100.00% | -- | 0.07 | 0.08 |
| -- | -- |
-- |
-- |
-- |
-- | Maximu | 0.13 | Minimum | 0.03 | ||||
| -- | -- | -- | As per the above there are 10 companies consisting of Market Share of 1% & Above | -- | -- | -- | -- | -- | -- | -- | |||
| -- | -- | -- | Sum of MAT value considered for price calculation | -- | -- | 27021.88 | (Rs. In Lakh) | -- | -- | -- | -- | ||
| -- | -- | -- | Sum of PTR per unit considered for price calculation | -- | -- | 2.3000 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | Number of Packs considered | -- | -- | 33 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | Average PTR | -- | -- | -- | 0.06970 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Add : 16% Retailer Margin | -- | -- | -- | 0.01115 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Ceiling Price (without local taxes) | -- | -- | 0.08085 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | % Reduction with compared to Highest Price | -- | -- | 46.15% | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | WPI factor @ 6.32% | -- | -- | -- | 0.00511 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Revised Ceiling Price (including WPI but without local taxes) |
-- | -- | -- | 0.08596 | S.O. 3127(E) dated 10.12.2014 | -- | -- | -- | ||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size | Unit | MAT Value as Sept. 2013 | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 26.2.2.1 | Glucose with Sodium Chloride Injection 5 % + 0.9% | -- | -- | Ahlcon Parenterals (India) Ltd. | 500 Ml | 500 | Injection | 124742848 | 4.99% | 22.24 | 0.04 | -- |
| -- | -- | -- | -- | -- | B Barun Medical (India) Pvt. Ltd. | 500 Ml | 500 | Injection | 59543152 | 2.38% | 22.24 | 0.04 | -- |
| -- | -- | -- | PVC Bag with two ports one port for extramedication and other for infusion | -- | Baxter(India) Pvt. Ltd. | 500 Ml | 500 | Injection | 99745855 | 3.99% | 41.48 | 0.08 | -- |
| -- | -- | -- | Plastic Bottles Nipple Head | -- | Baxter(India) Pvt. Ltd. | 500 Ml | 500 | Injection | 370535230 | 14.83% | 19.90 | 0.04 | -- |
| -- | -- | -- | -- | -- | Amanta Healthcare Limited | 500 ML | 500 | Injection | 146604504 | 5.87% | 23.88 | 0.05 | -- |
| -- | -- | -- | -- | -- | Amanta Healthcare Limited | 1000 ML | 1000 | Injection | 11653083 | 0.47% | 40.63 | 0.04 | -- |
| -- | -- | -- | -- | -- | Hindustan Antibiotics Ltd. | 500 Ml | 500 | Injection | 3153238 | 0.13% | 18.45 | 0.04 | -- |
| -- | -- | -- | Each 100 ml contains: Dextrose Anhydrous IP: 5 mg Sodium Chloride IP: 900 mg water for Injection Ip |
-- | Parenteral Drugs (India) Ltd. | 500 ML | 500 | Injection | 179397910 | 7.18% | 20.97 | 0.04 | -- |
| -- | -- | -- | Each 100 ml contains: Dextrose Anhydrous IP: 5 mg Sodium Chloride IP: 900 mg water for Injection Ip |
-- | Parenteral Drugs (India) Ltd. | 1000 ML | 1000 | Injection | 20191648 | 0.81% | 34.14 | 0.03 | -- |
| -- | -- | -- | Each 100 ml contains: Dextrose IP (as anhydrous) 5.0 gm Sodium chloride IP 0.9 gm water for Injection IP (Plastic FFS Bottle) |
-- | Nirma Limited | 100 ML | 100 | Injection | 169663 | 0.01% | 11.72 | 0.12 | -- |
| -- | -- | -- | -- | -- | Nirma Limited | 250 ML | 250 | Injection | 12581178 | 0.50% | 16.22 | 0.06 | -- |
| -- | -- | -- | -- | -- | Nirma Limited | 500 Ml | 500 | Injection | 688214621 | 27.55% | 22.02 | 0.04 | -- |
| -- | -- | -- | -- | -- | Nirma Limited | 1000 ML | 1000 | Injection | 46341511 | 1.85% | 37.48 | 0.04 | -- |
| -- | -- | -- | Plastic Bottle | -- | Fresenius Kabi India Pvt. Ltd | 1000 ML | 1000 | Injection | 9973192 | 0.40% | 38.24 | 0.04 | -- |
| -- | -- | -- | -- | -- | Fresenius Kabi India Pvt. Ltd | 500 ML | 500 | Injection | 152124656 | 6.09% | 22.47 | 0.04 | -- |
| -- | -- | -- | Poly | -- | Albert David Limited | 500 ML | 500 | Injection | 119443769 | 4.78% | 21.26 | 0.04 | -- |
| -- | -- | -- | Glass | -- | Albert David Limited | 500 ML | 500 | Injection | 12232516 | 0.49% | 24.61 | 0.05 | -- |
| -- | -- | -- | Nipple Head Plastic Bottle | -- | Claris Lifesciences Limited | 250 ML | 250 | Injection | 1436617 | 0.06% | 17.49 | 0.07 | -- |
| -- | -- | -- | Nipple Head Plastic Bottle | -- | Claris Lifesciences Limited | 500 Ml | 500 | Injection | 397227874 | 15.90% | 23.75 | 0.05 | -- |
| -- | -- | -- | Nipple Head Plastic Bottle | -- | Claris Lifesciences Limited | 1000 ML | 1000 | Injection | 34697623 | 1.39% | 40.42 | 0.04 | -- |
| -- | -- | -- | Dextrose Anhydrous 5 gm/100 ml | -- | IVES Drugs(India) Pvt. Ltd. | 500 Ml | 500 | Injection | 8192129 | 0.33% | 24.99 | 0.05 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | 2498202817 | 100.00% | -- | 0.05 | 0.06 |
| -- | -- |
-- |
-- |
-- |
-- | Maximum | 0.12 | Minimum | 0.03 | ||||
| -- | -- | -- | As per the above there are 9 companies consisting of Market Share of 1% & Above | -- | -- | -- | -- | -- | -- | -- | |||
| -- | -- | -- | Sum of MAT value considered for price calculation | -- | -- | 24868.57 | (Rs. In Lakh) | -- | -- | -- | -- | ||
| -- | -- | -- | Sum of PTR per unit considered for price calculation | -- | -- | 0.95000 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | Number of Packs considered | -- | -- | 19 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | Average PTR | -- | -- | -- | 0.05000 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Add : 16% Retailer Margin | -- | -- | -- | 0.00800 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Ceiling Price (without local taxes) | -- | -- | 0.05800 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | % Reduction with compared to Highest Price | -- | -- | 58.33% | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | WPI factor @ 6.32% | -- | -- | -- | 0.00367 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Revised Ceiling Price (including WPI but without local taxes) |
-- | -- | -- | 0.06167 | S.O. 3127(E) dated 10.12.2014 | -- | -- | -- | ||
| Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size | Unit | MAT Value as Sept. 2013 | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.0.1.2 | Ascorbic Acid 500 mg | LIMCEE TABS CHEW 500 MG x 10 |
-- |
ABBOTT HEALTHCARE | 500 mg | 10 | 1,089,888 | 10,245,000 | 12.33% | 9.00 | 0.90 |
-- |
|
-- |
-- |
CELIN TAB UNCOATED 500 MG x 25 |
-- |
GLAXOSMITHKLINE | 500 mg | 25 | 4,994,791 | 69,795,623 | 83.98% | 13.00 | 0.52 |
-- |
|
-- |
-- |
CELIN TABS 500 MG x 10 |
-- |
GLAXOSMITHKLINE | 500 mg | 10 | 385,922 | 2,207,490 | 2.66% | 6.00 | 0.60 |
-- |
|
-- |
-- |
CELIN TABS CHEW 500 MG x 10 |
-- |
GLAXOSMITHKLINE | 500 mg | 10 | 104,869 | 648,087 | 0.78% | 10.00 | 1.00 |
-- |
|
-- |
-- |
STANCEE TABS 500 MG x 10 |
-- |
STANDARD PHARMA | 500 mg | 10 | 24,261 | 216,540 | 0.26% | 10.00 | 1.00 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
83,112,740 | 100.00% |
-- |
0.76 | 0.88 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 1.00 | Minimum | 0.52 |
|
-- |
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
-- |
-- |
||||
|
-- |
-- |
Sum of MAT value considered for price calculation |
-- |
-- |
828.96 | (Rs. In Lakh) |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
Sum of PTR per unit considered for price calculation |
-- |
-- |
3.02 |
-- |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
Number of Packs considered |
-- |
-- |
-- |
4 |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
-- |
Average PTR |
-- |
-- |
-- |
0.76 |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
-- |
Add : 16% Retailer Margin |
-- |
-- |
-- |
0.12 |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
-- |
Ceiling Price |
-- |
-- |
-- |
0.88 |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
-- |
% Reduction with compared to Highest Price |
-- |
-- |
24.00% |
-- |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
WPI factor @ 6.32% |
-- |
-- |
-- |
0.06 |
-- |
-- |
|||||
|
-- |
Revised Ceiling Price (including WPI but without local taxes) |
-- |
-- |
-- |
0.94 | S.O. 3127(E) dated 10.12.2014 |
-- |
-- |
||||
| S.No | Unique No. as per NLEM | Composition as per NLEM | Company | Strength | Dosage Form | Pack Size | Price to Retailer | MAT Value as on Sep’2013 | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|---|
|
-- |
27.0.1.1 | Ascorbic Acid 100 mg | GLAXOSMITHKLINE | 100 mg | Tablet | 1000 | 152.00 | 15169 | 100.00% | 0.15 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
15169 |
-- |
0.15 |
|
-- |
Monopoly situation as M/s Glaxosmithkline is the only company manufacturing the formulation and has market share of 100% |
-- |
-- |
-- |
-- |
|||||
|
-- |
Average PTR per unit |
-- |
0.15 |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Price fixed in the relevant sub-section for other drugs is as follows: |
-- |
-- |
-- |
-- |
|||||
|
-- |
Section 27: – Vitamins and Minerals |
-- |
-- |
-- |
-- |
|||||
|
-- |
Medicines | Category | Route of Admn | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No | Date | % Reduction w.r.t. Highest Price | |
|
-- |
Ascorbic Acid 500 mg | P,S,T | Tablet | 500 mg | 1.13 | Proposed in 19th AM | 24.00% | |||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Average Reduction | 24.00% | ||
|
-- |
Therefore, PTR per unit | 0.15 X (1-24.00%) | 0.11 |
-- |
-- |
-- |
-- |
|||
|
-- |
Add: 16% Retailer Margin |
-- |
0.02 |
-- |
-- |
-- |
-- |
|||
|
-- |
Ceiling Price per unit |
-- |
0.13 |
-- |
-- |
-- |
-- |
|||
|
-- |
WPI factor @ 6.32% |
-- |
0.01 |
-- |
-- |
-- |
-- |
|||
|
-- |
Revised Ceiling Price (including WPI but without local taxes) |
-- |
0.14 | S.O. 3129(E) dated 10.12.2014 |
-- |
-- |
-- |
|||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Strength | Dosage Form | Pack Size | Price to Retailer | MAT Value as on Sep’2013 | MAT % | Price per unit | Ceiling price after 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
-- |
6.3.4.1 | Griseofulvin 125 MG | Glaxosmithkline | 125 mg | Tablet | 10 | 6.10 | 15823576 | 96.40% | 0.61 |
-- |
|
-- |
-- |
Griseofulvin 125 MG | IDPL | 125 mg | Tablet | 10 | 6.00 | 590083 | 3.60% | 0.60 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
16413659 | 100.00% | 0.61 | 0.71 |
|
-- |
-- |
-- |
-- |
Maximum | 0.61 | Minimum | 0.60 | ||||
|
-- |
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
-- |
Sum of MAT value considered for price calculation |
-- |
-- |
164.14 | (Rs. In Lakh) |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
Sum of PTR per unit considered for price calculation |
-- |
-- |
1.21 |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
Number of Packs considered |
-- |
-- |
-- |
2 |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
Average PTR |
-- |
-- |
-- |
0.61 |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
-- |
0.10 |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
Ceiling Price |
-- |
-- |
-- |
0.71 |
-- |
-- |
-- |
|||
|
-- |
% Reduction with compared to Highest Price |
-- |
-- |
0.00% |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
WPI factor @ 6.32% |
-- |
-- |
-- |
0.04 |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
Revised Ceiling Price (including WPI but without local taxes) |
-- |
-- |
-- |
0.75 | S.O. 3127(E) dated 10.12.2014 |
-- |
-- |
|||
| Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Unit | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per ml | Ceiling price after 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.2.8. | Sodium Meglumine Diatrizoat | Arco Lifesciences (I) Pvt. Ltd. |
-- |
ml | Injection | 20 | 114.69 | 393700 | 1.70% | 5.73 |
-- |
|
-- |
Sodium Meglumine Diatrizoat | Arco Lifesciences (I) Pvt. Ltd. |
-- |
ml | Injection | 50 | 271.40 | 31680 | 0.14% | 5.43 |
-- |
|
-- |
Sodium Meglumine Diatrizoat | Unijules Life Sciences Ltd. | Uroscan-60 | ml | Amp | 20 | 136.33 | 2274666 | 9.82% | 6.82 |
-- |
|
-- |
Sodium Meglumine Diatrizoat | Unijules Life Sciences Ltd. | Uroscan-60 | ml | Vial | 20 | 136.33 | 458758 | 1.98% | 6.82 |
-- |
|
-- |
Sodium Meglumine Diatrizoat | Unijules Life Sciences Ltd. | Uroscan-60 | ml | Vial | 50 | 312.76 | 457568 | 1.97% | 6.26 |
-- |
|
-- |
Sodium Meglumine Diatrizoat | Bayer Zydus Pharma | Urografin 60% | ml | Bottle | 100 | 729.44 | 657951 | 2.84% | 7.29 |
-- |
|
-- |
Sodium Meglumine Diatrizoat | Bayer Zydus Pharma | Urografin 60% | ml | Bottle | 400 | 2770.07 | 5735300 | 24.75% | 6.93 |
-- |
|
-- |
Sodium Meglumine Diatrizoat | J.B.Chemicals | Trzograf 60% | ml | Amp | 20 | 141.32 | 7315570 | 31.57% | 7.07 |
-- |
|
-- |
Sodium Meglumine Diatrizoat | J.B.Chemicals | Trzograf 60% | ml | Vial | 50 | 320.37 | 5846110 | 25.23% | 6.41 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
23171303 | 100.00% | 6.53 | 7.57 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 7.29 | minimum | 5.43 |
|
-- |
As per the above there are 4 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
-- |
231.71 | (Rs. In Lakh) |
-- |
-- |
||||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
-- |
58.76 |
-- |
-- |
-- |
-- |
|||
|
-- |
Number of Packs considered |
-- |
-- |
9 |
-- |
-- |
-- |
-- |
|||
|
-- |
Average PTR |
-- |
-- |
-- |
6.53 |
-- |
-- |
-- |
-- |
||
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
-- |
1.04 |
-- |
-- |
-- |
-- |
||
|
-- |
Ceiling Price |
-- |
-- |
-- |
7.57 |
-- |
-- |
||||
|
-- |
% Reduction with compared to Highest Price |
-- |
-- |
10.43% |
-- |
-- |
-- |
-- |
|||
|
-- |
WPI factor @ 6.32% |
-- |
-- |
-- |
0.48 |
-- |
-- |
-- |
-- |
||
|
-- |
Revised Ceiling Price (including WPI but without local taxes) |
-- |
-- |
8.05 | S.O. 3132(E) dated 10.12.2014 |
-- |
-- |
||||
| Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Unit | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.2.8. | Sodium Meglumine Diatrizoat | Arco Lifesciences (I) Pvt. Ltd. |
-- |
ml | Injection | 20 | 137.59 | 1622400 | 0.94% | 6.88 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | Arco Lifesciences (I) Pvt. Ltd. |
-- |
ml | Injection | 50 | 318.24 | 1039080 | 0.60% | 6.36 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | Unijules Life Sciences Ltd. | Uroscan-76 | ml | Amp | 20 | 176.43 | 3051357 | 1.77% | 8.82 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | Unijules Life Sciences Ltd. | Uroscan-76 | ml | Vial | 20 | 176.43 | 3123517 | 1.81% | 8.82 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | Unijules Life Sciences Ltd. | Uroscan-76 | ml | Vial | 50 | 368.90 | 1250571 | 0.72% | 7.38 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | Unijules Life Sciences Ltd. | Uroscan-76 | ml | Vial | 100 | 633.55 | 1077035 | 0.62% | 6.34 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | Bayer Zydus Pharma | Urografin 76% | ml | Bottle | 100 | 849.72 | 2054424 | 1.19% | 8.50 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | Bayer Zydus Pharma | Urografin 76% | ml | Bottle | 400 | 3331.10 | 48873158 | 28.28% | 8.33 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | Bayer Zydus Pharma | Urografin 76% | ml | Bottle | 50 | 413.27 | 2185558 | 1.26% | 8.27 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | Bayer Zydus Pharma | Urografin 76% | ml | Bottle | 100 | 758.39 | 13719651 | 7.94% | 7.58 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | J.B.Chemicals | Trzograf 76% | ml | Amp | 20 | 198.82 | 38594740 | 22.33% | 9.94 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | J.B.Chemicals | Trzograf 76% | ml | Vial | 50 | 422.40 | 5394050 | 3.12% | 8.45 |
-- |
| 14.2.8. | Sodium Meglumine Diatrizoat | J.B.Chemicals | Trzograf 76% | ml | Vial | 100 | 786.09 | 50849800 | 29.42% | 7.86 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
172835341 | Average | 7.96 | 9.23 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 9.94 | Minimum | 6.34 |
|
-- |
As per the above there are 4 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Sum of MAT value considered for price calculation |
-- |
-- |
1728.35 | (Rs. In Lakh) |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
-- |
103.53 |
-- |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
Number of Packs considered |
-- |
-- |
13 |
-- |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
Average PTR |
-- |
-- |
-- |
7.96 |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
-- |
1.27 |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Ceiling Price |
-- |
-- |
-- |
9.23 |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
% Reduction with compared to Highest Price |
-- |
-- |
19.92% |
-- |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
WPI factor @ 6.32% |
-- |
-- |
-- |
0.58 |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Revised Ceiling Price (including WPI but without local taxes) |
-- |
-- |
9.81 | S.O. 3132(E) dated 10.12.2014 |
-- |
-- |
-- |
-- |
||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size | Unit | MAT Value as on 30th Sept. 2013 | MAT % | PTR | Price per Unit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
-- |
27.0.8.1 | Vitamin A Capsules 50000IU | VITAMIN A Capusles 50K X |
-- |
USV | 50000 | 30 | Capsule | 2380266 | 100.00% | 16.77 | 0.56 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
2380266 |
-- |
-- |
-- |
|
-- |
-- |
Monopoly situation as M/s USV is the only company manufacturing the formulation and has market share of 100% |
-- |
|||||||||
|
-- |
-- |
PTR per unit |
-- |
0.56 |
-- |
|||||||
|
-- |
-- |
Price fixed in the relevant sub-section for other drugs is as follows: |
-- |
|||||||||
|
-- |
-- |
Section: 27 – Vitamins and Minerals |
-- |
-- |
-- |
-- |
||||||
|
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No | Date | % Reduction w.r.t. Highest Price |
-- |
|
|
-- |
-- |
Vitamin A | P,S,T | Tablets | 5000 IU | Data not available |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
Vitamin A | P,S,T | Capsules | 50000 IU | Under Consideration |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
Vitamin A | P,S,T | Capsules | 100000 IU | Data not available |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
Vitamin A | P,S,T | Injection | 50000 IU/ml | 1.22 | 18th | 2360(E) | 15.09.2014 | 26.15% |
-- |
|
|
-- |
Therefore, PTR per unit | 0.56X (1-26.15%) | 0.41 |
-- |
-- |
|||||||
|
-- |
Add: 16% Retailer Margin |
-- |
0.07 |
-- |
-- |
|||||||
|
-- |
Ceiling Price per unit |
-- |
0.48 |
-- |
-- |
|||||||
|
-- |
WPI factor @ 6.32% |
-- |
-- |
0.03 |
-- |
-- |
||||||
|
-- |
Ceiling Price (including WPI but without local taxes) | 0.51 | S.O. 3129(E) dated 10.12.2014 |
-- |
||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size(In ML) | Unit | MAT Value as on 30th Sept. 2013 | MAT % | PTR | Price per Unit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
-- |
24.1.1.5 | Chlorpromazine Hydrochloride | RELITIL INJ VIAL 25 MG 2 M |
-- |
Reliance | 25 mg/ml | 2 | ml | 65541 | 100.00% | 2.00 | 1.00 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
65541 |
-- |
-- |
-- |
|
-- |
-- |
Monopoly situation as M/s Reliance is the only company manufacturing the formulation and has market share of 100% |
-- |
|||||||||
|
-- |
-- |
PTR per unit |
-- |
1.00 |
-- |
|||||||
|
-- |
-- |
Price fixed in the relevant sub-section for other drugs is as follows: |
-- |
|||||||||
|
-- |
-- |
-- |
-- |
|||||||||
|
-- |
-- |
Section :24-Psychotherapeutic Medicines |
-- |
-- |
-- |
-- |
||||||
|
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No | Date | % Reduction w.r.t. Highest Price |
-- |
|
|
-- |
-- |
Chlorpromazine HCL | P,S,T | Tablet | 25 mg | 0.29 | 17th | 2094(E) | 20.08.2014 | 4.17% |
-- |
|
|
-- |
-- |
Chlorpromazine HCL | P,S,T | Tablet | 50 mg | 0.39 | 18th | 2351(E) | 15.09.2014 | 0.00% |
-- |
|
|
-- |
-- |
Chlorpromazine HCL | P,S,T | Tablet | 100 mg | 0.64 | 18th | 2351(E) | 15.09.2014 | 0.00% |
-- |
|
|
-- |
-- |
Chlorpromazine HCL | P,S,T | Syrup | 25 mg/5 ml | Data not available |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
Chlorpromazine HCL | P,S,T | Injection | 25 mg/ml | Under consideration |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
Average Reduction | 1.39% |
-- |
|||||||
|
-- |
Therefore, PTR per unit | 1.00X (1-1.39%) | 0.99 |
-- |
-- |
|||||||
|
-- |
Add: 16% Retailer Margin |
-- |
0.16 |
-- |
-- |
|||||||
|
-- |
Ceiling Price per unit |
-- |
1.15 |
-- |
-- |
|||||||
|
-- |
WPI factor @ 6.32% |
-- |
-- |
0.07 |
-- |
-- |
||||||
|
-- |
Ceiling Price (including WPI but without local taxes) | 1.22 | S.O. 3129(E) dated 10.12.2014 |
-- |
||||||||
| S.No | Unique No. as per NLEM | Composition as per NLEM | Company | Pack Description | Strength | Dosage Form | Pack Size | Price to Retailer | MAT Value as on May’12 | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
-- |
6.4.2.2.1 | Efavirenz | HETERO HEALTHCARE LTD | ESTIVA 600 MG CAPSULE 1 | 600 mg | Capsule | 10 | 533.81 | 7819225 | 76.21% | 53.38 |
|
-- |
-- |
-- |
HETERO HEALTHCARE LTD | ESTIVA 600 MG CAPSULE 3 | 600 mg | Capsule | 30 | 1577.14 | 2441413 | 23.79% | 52.57 |
|
-- |
-- |
-- |
-- |
-- |
10260638 | 100.00% | 52.98 | ||||
|
-- |
Monopoly situation as M/s Hetereo is the only company manufacturing the formulation and has market share of 100% |
-- |
-- |
-- |
-- |
-- |
-- |
||||
|
-- |
Average PTR per unit |
-- |
52.98 |
-- |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Price fixed in the relevant sub-section for other drugs is as follows: |
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
Medicines | Category | Route of Admn | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No | Date | % Reduction w.r.t. Highest Price |
-- |
|
|
-- |
Efavirenz | S,T | Capsule | 200 mg | 23.16 | 8th | 3359 | 05.11.2013 | 8.94% |
-- |
|
|
-- |
Efavirenz | S,T | Capsule | 600 mg | Under Consideration |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Average Reduction | 8.94% |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Therefore, PTR per unit | 52.98 X (1-8.94%) | 48.24 |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Add: 16% Retailer Margin |
-- |
7.72 |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Ceiling Price per unit |
-- |
55.96 |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
WPI factor @ 6.32% |
-- |
3.54 |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Revised Ceiling Price (including WPI but without local taxes) |
-- |
59.50 | S.O. 3128(E) dated 10.12.2014 |
-- |
-- |
-- |
-- |
|||
|
-- |
-- |
-- |
-- |
Source of Data Pharma Trac (May 2012) |
-- |
||||||
| S.No. | NLEM specification | Composition of the Product | Brand Name | Company | Dosage Form | Pack size (Kg) | Price to Retailer (Rs.) | MAT Value | MAT % | Price per kg | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.2.1 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | Bleaching powder contains | Bleaching powder 32% | Not available | Priyanka Chemicals P Lt | Powder | 25 | 351.88 | 9,512,128 | 44.63% | 14.08 |
-- |
| 2 | than 30% w/v of available c | Bleaching powder 32% | Not available | Rajashree Chloro Chem | Powder | 25 | 351.88 | 9,800,000 | 45.98% | 14.08 |
-- |
| 3 | (as per IP) | Hydrated lime 90% liquid chlo | Not available | Sular Pharma Chemicals | Powder | 25 | 355 | 2,002,000 | 9.39% | 14.20 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
21,314,128 | 100.00% | 14.12 | 16.38 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 14.20 | Minimum | 14.08 |
|
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Sum of MAT value considered for price calculation |
-- |
-- |
213.14 | (Rs. in lakh) |
-- |
|||||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
-- |
42.35 |
-- |
-- |
|||||
|
-- |
Number of Packs considered |
-- |
-- |
3 |
-- |
-- |
|||||
|
-- |
Average PTR |
-- |
-- |
14.12 |
-- |
-- |
|||||
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
2.26 |
-- |
-- |
|||||
|
-- |
Ceiling Price (without local taxes) |
-- |
-- |
16.38 |
-- |
-- |
|||||
|
-- |
% Reduction with compared to Highest Price |
-- |
-- |
0.56% |
-- |
-- |
|||||
|
-- |
WPI @ 6.32% |
-- |
-- |
1.04 |
-- |
-- |
-- |
-- |
|||
|
-- |
Ceiling Price with WPI (excluding local taxes) |
-- |
-- |
17.42 | per Kg | S.O. 3126(E) dated 10.12.2014 | |||||
|
-- |
-- |
Source of Data Pharma Trac (May 2012) | |||||||||
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size (ML) | Price to Retailer (Rs.) | MAT Value | MAT % | Price per ml | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|
| 17.6.2 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | Zinc Sulfate syrup 20mg/5m | ZIMBO 20 MG SYRUP 50 ML | ABBOTT HEALTHCARE P | Syrup | 50 | 24.38 | 3,199,729 | 2.10% | 0.49 |
-- |
| 2 | Zinc Sulfate syrup 20mg/5m | ZINCRIS 20 MG SYRUP 60 M | CIPLA LTD. | Syrup | 60 | 22.10 | 6,652,697 | 4.36% | 0.37 |
-- |
| 3 | Zinc Sulfate syrup 20mg/5ml | ZINFORT 20 MG SYRUP 50 ML | HETERO HEALTHCARE LT | Syrup | 50 | 22.48 | 16,979 | 0.01% | 0.45 |
-- |
| 4 | Zinc Sulfate syrup 20mg/5ml | JINK 20 MG SYRUP 60 ML | LINCOLN PHARMACEUTIC | Syrup | 60 | 24.54 | 329,794 | 0.22% | 0.41 |
-- |
| 5 | Zinc Sulfate syrup 20mg/5m | ZINCOLIFE 20 MG SYRUP 50 | MANKIND PHARMACEUTI | Syrup | 50 | 24.38 | 16,649,592 | 10.91% | 0.49 |
-- |
| 6 | Zinc Sulfate syrup 20mg/5m | ZINC UP 20 MG/5ML SYRUP | MAPRA LABORATORIES | Syrup | 50 | 44.99 | 4,870,248 | 3.19% | 0.90 |
-- |
| 7 | Zinc Sulfate syrup 20mg/5ml | ZEMIN 20 MG SOLUTION 60 M | MENARINI INDIA | Solution | 60 | 27.05 | 481,890 | 0.32% | 0.45 |
-- |
| 8 | Zinc Sulfate syrup 20mg/5ml | ZIDUST 20 MG SYRUP 70 ML | MERCURY HEALTH CARE | Syrup | 70 | 34.14 | 1,237,072 | 0.81% | 0.49 |
-- |
| 9 | Zinc Sulfate syrup 20mg/5m | ZIFRA 20 MG/5ML SYRUP 60 | MICRO LABS LTD | Syrup | 60 | 25.90 | 5,226,896 | 3.42% | 0.43 |
-- |
| 10 | Zinc Sulfate syrup 20mg/5m | ZINSY 20 MG/5ML SYRUP 60 | PHARMED LTD | Syrup | 60 | 26.29 | 3,689,381 | 2.42% | 0.44 |
-- |
| 11 | Zinc Sulfate syrup 20mg/5m | MINTONIA 20 MG SYRUP 60 | SERUM INSTITUTE OF IN | Syrup | 60 | 23.62 | 3,151,974 | 2.07% | 0.39 |
-- |
| 12 | Zinc Sulfate syrup 20mg/5ml | ZOVULES 20 MG SYRUP 60 M | TRENDS PHARMA PVT. LT | Syrup | 60 | 26.67 | 221,473 | 0.15% | 0.44 |
-- |
| 13 | Zinc Sulfate syrup 20mg/5m | ZN 20 MG SYRUP 100 ML | WALLACE PHARMACEUTI | Syrup | 100 | 46.48 | 31,610,736 | 20.71% | 0.46 |
-- |
| 14 | Zinc Sulfate syrup 20mg/5m | ZN 20 MG SYRUP 50 ML | WALLACE PHARMACEUTI | Syrup | 50 | 25.30 | 10,233,931 | 6.71% | 0.51 |
-- |
| 15 | Zinc Sulfate syrup 20mg/5m | ZINCONIA 20 MG SYRUP 50 | ZUVENTUS HEALTHCARE | Syrup | 50 | 23.90 | 4,616,476 | 3.02% | 0.48 |
-- |
| 16 | Zinc Sulfate syrup 20mg/5m | ZINCONIA 20 MG/5ML SYRU | ZUVENTUS HEALTHCARE | Syrup | 100 | 46.04 | 60,426,809 | 39.59% | 0.46 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
152,615,677 | 100.00% | 0.49 | 0.57 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum |
-- |
Minimum | 0.37 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
As per the above there are 9 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Sum of MAT value considered for price calculation |
-- |
-- |
1503.28 | (Rs. in lakh) |
-- |
||||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
-- |
5.42 |
-- |
-- |
||||
|
-- |
Number of Packs considered |
-- |
-- |
11 |
-- |
-- |
||||
|
-- |
Average PTR |
-- |
-- |
0.49 |
-- |
-- |
||||
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
0.08 |
-- |
-- |
||||
|
-- |
Ceiling Price (without local taxes) |
-- |
-- |
0.57 |
-- |
-- |
||||
|
-- |
% Reduction with compared to Highest Price |
-- |
-- |
45.56% |
-- |
-- |
||||
|
-- |
WPI @ 6.32% |
-- |
-- |
0.04 |
-- |
-- |
-- |
-- |
||
|
-- |
Ceiling Price with WPI (excluding local taxes) |
-- |
-- |
0.61 | S.O. 3126(E) dated 10.12.2014 |
-- |
||||
|
-- |
-- |
-- |
-- |
Source of Data Pharma Trac (May 2012) |
-- |
-- |
||||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size (ML) | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|
| 25.2.1 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | Codeine phosphate | MONTOKUF 15 MG SYRUP 60 | SHREYA LIFE SCIENCES P | 15mg/5ml | 60 | 35.50 | 1545838 | 100.00% | 0.59 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
1,545,838 | 100.00% | 0.59 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Monopoly situation as only M/s. Shreya Life Sciences is the known manufacturer |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
PTR per unit |
-- |
-- |
0.59 |
-- |
-- |
-- |
-- |
-- |
|
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: |
-- |
-- |
-- |
-- |
||||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Section: 25.2 –Antitussives |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
|
-- |
Codeine Phosphate | S,T | Tablets | 10 mg% | 0.92 | 16th | 1782 | 10.07.2014 | 13.71% |
|
-- |
Codeine Phosphate | P,S,T | Syrup | 15mg/5ml | Under consideration |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
Average Reduction | 13.71% | ||||
|
-- |
Therefore, PTR per unit |
-- |
0.59 x(1-13.71%) |
-- |
0.51 |
-- |
-- |
-- |
|
|
-- |
Add : 16% Retailer Margin |
-- |
0.08 |
-- |
-- |
-- |
|||
|
-- |
Ceiling Price (without local taxes) |
-- |
0.59 |
-- |
-- |
-- |
|||
|
-- |
% Reduction with compared to Highest Price |
-- |
13.71% |
-- |
-- |
-- |
|||
|
-- |
WPI @ 6.32% |
-- |
0.04 |
-- |
-- |
-- |
-- |
||
|
-- |
Ceiling Price with WPI (excluding local taxes) |
-- |
0.63 | S.O. 3128(E) dated 10.12.2014 |
-- |
||||
|
-- |
-- |
-- |
-- |
Source of Data Pharma Trac (May 2012) |
-- |
||||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size (ML) | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|
| 1.3.2 | Diazepam |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | Slipizem 5 mg suppository | Slipizem 5 mg suppository 5 | Bliss Chemicals & Pharmac | Suppository | 5 | 43.04 | 44,955 | 100.00% | 8.61 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
44,955 | 100.00% | 8.61 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Monopoly situation as only M/s. Bliss Chemicals & Pharmaceuticals is the known manufacturer |
-- |
|||||||
|
-- |
PTR per unit |
-- |
-- |
8.61 |
-- |
-- |
-- |
-- |
-- |
|
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: |
-- |
-- |
-- |
-- |
||||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Section: 1.3 – Preoperative Medication and Sedation for short term procedures |
-- |
|||||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
|
-- |
Diazepam | P,S,T | Tablets | 5 mg | 1.32 | 2 | 1832 | 21.06.2013 | 55.05% |
|
-- |
Diazepam | Injection | 5 mg / ml | 5.59 | 1 | 1549 | 14.06.2013 | 41.71% | |
|
-- |
Diazepam | S, T | Syrup | 2mg/5ml | No data |
-- |
-- |
-- |
-- |
|
-- |
Diazepam | Suppository | 5 mg | Under consideration |
-- |
-- |
|||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Average Reduction | 48.38% | |
|
-- |
Therefore, PTR per unit |
-- |
8.61x(1-38.75%) |
-- |
4.44 |
-- |
-- |
-- |
|
|
-- |
Add : 16% Retailer Margin |
-- |
0.71 |
-- |
-- |
-- |
|||
|
-- |
Ceiling Price (without local taxes) |
-- |
5.15 |
-- |
-- |
-- |
|||
|
-- |
% Reduction with compared to Highest Price |
-- |
48.38% |
-- |
-- |
-- |
|||
|
-- |
WPI @ 6.32% |
-- |
0.33 |
-- |
-- |
-- |
-- |
||
|
-- |
Ceiling Price with WPI (excluding local taxes) |
-- |
5.48 | S.O. 3128(E) dated 10.12.2014 |
-- |
||||
|
-- |
|||||||||
|
-- |
-- |
-- |
-- |
Source of Data Pharma Trac (May 2012) |
-- |
||||
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size (ML) | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit | – |
|---|---|---|---|---|---|---|---|---|---|---|
| 18.3.1.3 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | Hormone releasing IUD | MULTILOAD 250 MG DEVICE 1 | ORGANON (INDIA) LTD | IUD | 1 | 307.2 | 42,177,494 | 69.37% | 307.20 |
-- |
| 2 | Hormone releasing IUD | MULTILOAD 375 MG DEVICE 1 | ORGANON (INDIA) LTD | IUD | 1 | 438.6 | 17,234,787 | 28.35% | 438.60 |
-- |
| 3 | Hormone releasing IUD | NUVA RING SACHET 1 | ORGANON (INDIA) LTD | IUD | 1 | 632 | 885,432 | 1.46% | 632.00 |
-- |
| 4 | Hormone releasing IUD | ZYLOAD DEVICE | ZYDUS CADILA | IUD | 1 | 178.92 | 500,185 | 0.82% | 178.92 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
60,797,898 | 100.00% | 459.27 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Monopoly situation as only M/s. Organon (India Ltd) is the known manufacturer |
-- |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
PTR per unit |
-- |
-- |
459.27 |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: |
-- |
-- |
-- |
-- |
-- |
||||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||||
|
-- |
Section: 18 .3.1 –Hormonal contraceptives |
-- |
-- |
-- |
-- |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
-- |
|
-- |
Ethinylestradiol +Levonorgesterol | P,S,T | Tablets | 0.03mg +0.15 mg | 3.05 | 4th | 2067 | 05.07.2013 | 19.67% |
-- |
|
-- |
Ethinylestradiol + Norethisterone | P,S,T | Tablets | 0.035 mg +1.0 mg | No data |
-- |
-- |
-- |
-- |
-- |
|
-- |
Hormone releasing IUD | T | Levonorgesterol releasing | IUD | Under consideration |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
Average Reduction | 19.67% |
-- |
||||
|
-- |
Therefore, PTR per unit |
-- |
459.27x(1-19.67%) |
-- |
368.93 |
-- |
-- |
-- |
||
|
-- |
Add : 16% Retailer Margin |
-- |
59.03 |
-- |
-- |
-- |
-- |
|||
|
-- |
Ceiling Price (without local taxes) |
-- |
427.96 |
-- |
-- |
-- |
-- |
|||
|
-- |
% Reduction with compared to Highest Price |
-- |
19.67% |
-- |
-- |
-- |
-- |
|||
|
-- |
WPI @ 6.32% |
-- |
27.05 |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Ceiling Price with WPI (excluding local taxes) |
-- |
455.01 | S.O. 3128(E) dated 10.12.2014 |
-- |
|||||
|
-- |
Source of data: Pharma Trac |
-- |
||||||||
|
-- |
Molecule_Desc | Market | PACK_DESC | BRANDS | MANUFACTURE | COMPANY | Pack (ML) | MAT May’12 | PTR May’12 | PTR per ML |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
IODINE | Iodine Solution 8 mg / 5 ml | COLLOSOL IODINE LIQUID 8 M | COLLOSOL IODINE | SOLVAY PHARMA | ABBOTT* | 100 | 11205591 | 30.42 | 0.30 |
|
-- |
||||||||||
|
-- |
-- |
Monopoly situation as |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
83338581 |
|
-- |
-- |
PTR per unit |
-- |
-- |
0.30 |
-- |
-- |
-- |
-- |
-- |
|
-- |
-- |
Price fixed in the relev |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
||||||||||
|
-- |
18.8: Thyroid and antithyroid medicines |
-- |
||||||||
|
-- |
-- |
Drugs | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price | Meeting No. | S.O.No. | Date | % Reduction w.r.t. Highest Price |
|
-- |
1 | Carbimazole | P,S,T | Tablets | 5 mg | 1.77 | 1st | 1668 | 14.06.2013 | 9.76 |
|
-- |
2 | Carbimazole | P,S,T | Tablets | 10 mg | 3.43 | 1st | 1669 | 14.06.2013 | 5.41 |
|
-- |
3 | Levothroxine | P,S,T | Tablets | 50 ug | 1.01 | 4th | 2069 | 05.07.2013 | 22.89 |
|
-- |
4 | Levothroxine | P,S,T | Tablets | 100 ug | 1.11 | 2nd | 1815 | 21.06.2013 | 13.98 |
|
-- |
5 | Iodine | S,T | Solution | 8 mg/5ml | Under consideration |
-- |
-- |
-- |
-- |
|
-- |
Average | 13.01 | ||||||||
|
-- |
Therefore, PTR per unit |
-- |
-- |
0.30 x(1-13.01%) | 0.26 |
-- |
||||
|
-- |
Add: 16% Retailer Margin |
-- |
-- |
-- |
0.04 |
-- |
||||
|
-- |
Ceiling Price per unit |
-- |
-- |
-- |
0.30 |
-- |
||||
|
-- |
WPI @ 6.32% |
-- |
-- |
-- |
0.02 |
-- |
||||
|
-- |
Ceiling price with WPI |
-- |
-- |
-- |
0.32 | per ml | S.O. 3128(E) dated 10.12.2014 | |||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size | Unit | MAT Value as on 30th Sept. 2013(In Crs.) | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | CIPAD E/E DROPS 0.30 % 5 M | CIPAD | ALBERT DAVID | 0.3 | 5 | ML | 0.007 | 0.03% | 6.18 | 1.24 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | CIPRO-CENT E/E DROPS 0.30 | CIPRO-CENT | CENTAUR | 0.3 | 5 | ML | 0.143 | 0.64% | 6.18 | 1.24 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | CIPLOX E/E DROPS 0.30 % 5 | CIPLOX | CIPLA | 0.3 | 5 | ML | 15.215 | 67.97% | 5.96 | 1.19 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | CIPLOX E/E DROPS 0.30 % 10 | CIPLOX | CIPLA | 0.3 | 10 | ML | 0.419 | 1.87% | 12.90 | 1.29 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | ZOXAN EYE DROPS 0.30 % 5 | ZOXAN | FDC | 0.3 | 5 | ML | 1.834 | 8.19% | 6.17 | 1.23 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | ZOXAN EYE DROPS 10 ML x 1 | ZOXAN | FDC | 0.3 | 10 | ML | 0.052 | 0.23% | 12.90 | 1.29 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | GB-FLOX E/E DROPS 0.30 % | GB-FLOX | GREENCO | 0.3 | 5 | ML | 0.002 | 0.01% | 6.45 | 1.29 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | CEPROLEN E/E DROPS 0.30 | CEPROLEN | INDOCO* | 0.3 | 5 | ML | 0.226 | 1.01% | 6.24 | 1.25 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | ADIFLOX E/E DROPS 0.30 % 1 | ADIFLOX | INTAS PHARMA* | 0.3 | 10 | ML | 0.042 | 0.19% | 7.06 | 0.71 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | JOXIN EYE DROPS 0.3 % 5 M | JOXIN | JAWA | 0.3 | 5 | ML | 0.034 | 0.15% | 5.79 | 1.16 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | CIPROZEN E/E DROPS 0.30 % | CIPROZEN | KLAR SEHEN | 0.3 | 5 | ML | 0.050 | 0.22% | 6.45 | 1.29 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | CEFLOX E/E DROPS 30 % 10 | CEFLOX | LABORATE PHAR | 0.3 | 10 | ML | 1.027 | 4.59% | 8.40 | 0.84 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | MICROFLOX E/E DROPS 0.30 | MICROFLOX | MICRO LABS* | 0.3 | 5 | ML | 0.268 | 1.20% | 6.12 | 1.22 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | MICROFLOX EYE DROPS 0.30 | MICROFLOX | MICRO LABS* | 0.3 | 10 | ML | 0.003 | 0.01% | 12.90 | 1.29 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | NUCIPRO E/E DROPS 0.30 % | NUCIPRO | NULIFE | 0.3 | 5 | ML | 0.009 | 0.04% | 5.35 | 1.07 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | CINFAX E/E DROPS 5 ML x 1 | CINFAX | OPTHO REMEDIE | 0.3 | 5 | ML | 0.179 | 0.80% | 6.11 | 1.22 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | CIFRAN E/E DROPS 3 MG 10 | CIFRAN | RANBAXY* | 0.3 | 10 | ML | 2.678 | 11.96% | 12.90 | 1.29 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | ULTIFLOX OPHTH.SOLUT 0.30 | ULTIFLOX | SUNWAYS | 0.3 | 10 | ML | 0.010 | 0.05% | 11.11 | 1.11 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | NUGEN E/E DROPS 0.30 % 5 | NUGEN | SYNTHO PHARMA | 0.3 | 5 | ML | 0.028 | 0.13% | 6.45 | 1.29 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | NUGEN EYE DROPS 0.30 % 5 | NUGEN | SYNTHO PHARMA | 0.3 | 5 | ML | 0.004 | 0.02% | 6.45 | 1.29 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | CIPROMAC E/E DROPS 0.30 | CIPROMAC | TORQUE PHARM | 0.3 | 10 | ML | 0.121 | 0.54% | 6.00 | 0.60 | -- |
| -- | 21.1.2.1 | CIPROFLOXACIN HYDROCHLORI | BIOCIP E/E DROPS 0.30 % 10 | BIOCIP | ZYDUS CADILA* | 0.3 | 10 | ML | 0.034 | 0.15% | 12.90 | 1.29 | -- |
| -- |
-- |
-- | 22.385 | 100.00% | -- | 1.21 | 1.40 | ||||||
| -- |
-- |
-- | Maximum | 1.29 | Minimum | 0.84 | -- | ||||||
| -- |
-- |
||||||||||||
| -- | -- | As per the above there are 6 companies consisting of Market Share of 1% & Above | -- | -- | -- | -- |
-- |
||||||
| -- | -- | Sum of MAT value considered for price calculation |
-- |
2172.00 | (Rs. in Lakhs) | -- | -- |
-- |
|||||
| -- | -- | Sum of PTR per unit considered for price calculation |
-- |
10.89 | -- | -- |
-- |
||||||
| -- | -- | Number of Packs considered |
-- |
9 | -- | -- |
-- |
||||||
| -- | -- | Average PTR |
-- |
1.21 | -- | -- |
-- |
||||||
| -- | -- | Add : 16% Retailer Margin |
-- |
0.19 | -- | -- |
-- |
||||||
| -- | -- | Ceiling Price (without local taxes) |
-- |
1.40 | -- | -- |
-- |
||||||
| -- | -- | % Reduction with compared to Highest Price |
-- |
6.20% | -- | -- |
-- |
||||||
| -- | -- | WPI factor @ 6.32% | -- |
-- |
0.09 |
-- |
|||||||
| -- | -- | Revised Ceiling Price (including WPI but without local taxes) |
-- |
-- |
1.49 | S.O. 3130(E) da |
-- |
||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | Company | Strength | Pack Size | Unit | MAT Value as on 30th Sept. 2013 | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 6.4.2.4.2 & 6.5.4.1 | SULFAMETHOXAZOLE + TRIMET | ANTRIMA TAB UNCOATED 80 | ABBOTT* | 800/160 | 10 | Tabs | 5325865 | 2.50% | 12.35 | 1.24 |
-- |
| 2 |
-- |
SULFAMETHOXAZOLE + TRIMET | BACTRIM TABS DS 800 MG x | ABBOTT* | 800/160 | 10 | Tabs | 102982025 | 48.30% | 12.35 | 1.24 |
-- |
| 3 |
-- |
SULFAMETHOXAZOLE + TRIMET | TORRID TABS DS 800 MG x 10 | ALEMBIC | 800/160 | 10 | Tabs | 13699 | 0.01% | 8.93 | 0.89 |
-- |
| 4 |
-- |
SULFAMETHOXAZOLE + TRIMET | TABROL TABS DS 800 MG x | ARISTO PHARMA* | 800/160 | 10 | Tabs | 6101807 | 2.86% | 9.25 | 0.93 |
-- |
| 5 |
-- |
SULFAMETHOXAZOLE + TRIMET | CIPLIN TABS DS 800 MG x 10 | CIPLA | 800/160 | 10 | Tabs | 7466392 | 3.50% | 10.41 | 1.04 |
-- |
| 6 |
-- |
SULFAMETHOXAZOLE + TRIMET | COPRIME TABS DS 800 MG x | CONCEPT PHARMA | 800/160 | 10 | Tabs | 11732 | 0.01% | 7.50 | 0.75 |
-- |
| 7 |
-- |
SULFAMETHOXAZOLE + TRIMET | COTRI TAB UNCOATED 160 M | DECCAN HEALTH | 800/160 | 10 | Tabs | 10931 | 0.01% | 15.33 | 1.53 |
-- |
| 8 |
-- |
SULFAMETHOXAZOLE + TRIMET | TRIMEX TABS DS 160 MG x 10 | FRANKLIN LABS | 800/160 | 10 | Tabs | 131292 | 0.06% | 12.60 | 1.26 |
-- |
| 9 |
-- |
SULFAMETHOXAZOLE + TRIMET | SEPMAX TAB UNCOATED 800 | GLAXOSMITHKLINE* | 800/160 | 10 | Tabs | 38188002 | 17.91% | 11.10 | 1.11 |
-- |
| 10 |
-- |
SULFAMETHOXAZOLE + TRIMET | SEPMAX TAB UNCOATED 800 | GLAXOSMITHKLINE* | 800/160 | 200 | Tabs | 391620 | 0.18% | 223.40 | 1.12 |
-- |
| 11 |
-- |
SULFAMETHOXAZOLE + TRIMET | SEPTRAN TABS DS 800 MG x | GLAXOSMITHKLINE* | 800/160 | 10 | Tabs | 320454 | 0.15% | 9.56 | 0.96 |
-- |
| 12 |
-- |
SULFAMETHOXAZOLE + TRIMET | NEUROPRIM TABS 800 MG x | IND-SWIFT | 800/160 | 10 | Tabs | 1189780 | 0.56% | 7.40 | 0.74 |
-- |
| 13 |
-- |
SULFAMETHOXAZOLE + TRIMET | COTRIMOX INGA TABS DS 800 | INGA | 800/160 | 10 | Tabs | 107453 | 0.05% | 12.61 | 1.26 |
-- |
| 14 |
-- |
SULFAMETHOXAZOLE + TRIMET | TRIMZOLE TABS DS 160 MG x | LABORATE PHARMA | 800/160 | 10 | Tabs | 656868 | 0.31% | 7.80 | 0.78 |
-- |
| 15 |
-- |
SULFAMETHOXAZOLE + TRIMET | LARPRIM TABS DS 800 MG x | LARK LABS | 800/160 | 10 | Tabs | 88311 | 0.04% | 9.50 | 0.95 |
-- |
| 16 |
-- |
SULFAMETHOXAZOLE + TRIMET | L-TRIM TAB UNCOA.DS 800 M | LEBEN LABS | 800/160 | 10 | Tabs | 90303 | 0.04% | 9.77 | 0.98 |
-- |
| 17 |
-- |
SULFAMETHOXAZOLE + TRIMET | COTRIMOXAZOLE TABS DS 80 | NATCO PHARMA | 800/160 | 10 | Tabs | 51052 | 0.02% | 10.57 | 1.06 |
-- |
| 18 |
-- |
SULFAMETHOXAZOLE + TRIMET | TRIMOZOL TABS DS 800 MG x | NATCO PHARMA | 800/160 | 200 | Tabs | 279020 | 0.13% | 8.27 | 0.04 |
-- |
| 19 |
-- |
SULFAMETHOXAZOLE + TRIMET | COTRIMOXAZOLE TABS DS 80 | OMEGA REMEDIES | 800/160 | 10 | Tabs | 396005 | 0.19% | 7.40 | 0.74 |
-- |
| 20 |
-- |
SULFAMETHOXAZOLE + TRIMET | RANCOTRIM TAB UNCOATED | RANBAXY* | 800/161 | 10 | Tabs | 1126761 | 0.53% | 10.37 | 1.04 |
-- |
| 21 |
-- |
SULFAMETHOXAZOLE + TRIMET | COTRIMAX TAB UNCOATED 1 | RPG LIFE SCIENCES | 800/162 | 10 | Tabs | 21810 | 0.01% | 8.53 | 0.85 |
-- |
| 22 |
-- |
SULFAMETHOXAZOLE + TRIMET | BACTOSTAB TABS DS 800 M | SIRI | 800/163 | 10 | Tabs | 116267 | 0.05% | 8.91 | 0.89 |
-- |
| 23 |
-- |
SULFAMETHOXAZOLE + TRIMET | CO-TRIMOXAZOLE TABS DS | ZYDUS CADILA* | 800/164 | 10 | Tabs | 73763 | 0.03% | 8.50 | 0.85 |
-- |
| 24 |
-- |
SULFAMETHOXAZOLE + TRIMET | ORIPRIM TABS DS 800 MG x | ZYDUS CADILA* | 800/165 | 10 | Tabs | 48060012 | 22.54% | 11.28 | 1.13 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
213201224 | 100.00% |
-- |
1.07 | 1.24 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 1.24 | Minimum | 0.85 |
|
-- |
||||||||||||
|
-- |
As per the above there are 5 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
|||||||
|
-- |
Sum of MAT value considered for price calculation | 2089.00 | (Rs. in Lakhs) |
-- |
-- |
|||||||
|
-- |
Sum of PTR per unit considered for price calculation | 9.60 |
-- |
-- |
-- |
|||||||
|
-- |
Number of Packs considered | 9 |
-- |
-- |
-- |
|||||||
|
-- |
Average PTR | 1.07 |
-- |
-- |
-- |
|||||||
|
-- |
Add : 16% Retailer Margin | 0.17 |
-- |
-- |
-- |
|||||||
|
-- |
Ceiling Price (without local taxes) | 1.24 |
-- |
-- |
-- |
|||||||
|
-- |
% Reduction with compared to Highest Price | 13.71% |
-- |
-- |
-- |
|||||||
|
-- |
WPI factor @ 6.32% | 0.08 |
-- |
|||||||||
|
-- |
Revised Ceiling Price (including WPI but without local taxes) |
1.32 | S.O. 3133(E) dated 10.12.2014 |
-- |
||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | Company | Pack Size (ML) | Unit | MAT Value as on 31st May 2012 | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 16.0.3.2 | Mannitol Injection 20% | MANNITOL INFUS VIAL 20 % 100 ML x 1 | Abbott Healthcare | 100 | Injection | 720656 | 0.28% | 19.54 | 0.20 |
-- |
| 2 |
-- |
Mannitol Injection 20% | MANNITOL SOLUT.INJ 20 % 1 | ALBERT DAVID | 100 | Injection | 3,396,336 | 1.33% | 29.30 | 0.29 |
-- |
| 3 |
-- |
Mannitol Injection 20% | MANNITOL SOLUT.INJ 20 % 3 | ALBERT DAVID | 350 | Injection | 7,885,268 | 3.10% | 57.85 | 0.17 |
-- |
| 4 |
-- |
Mannitol Injection 20% | MANNITOL INFUS VIAL 20 % 100 ML x 1 | ALKEM* | 100 | Injection | 520,793 | 0.20% | 60.19 | 0.60 |
-- |
| 5 |
-- |
Mannitol Injection 20% | MANNITOL SOLUT.INJ 20 % 1 | BAXTER | 100 | Injection | 19,110,139 | 7.50% | 27.80 | 0.28 |
-- |
| 6 |
-- |
Mannitol Injection 20% | MANNITOL SOLUT.INJ 20 % 3 | BAXTER | 350 | Injection | 2,432,366 | 0.95% | 61.00 | 0.17 |
-- |
| 7 |
-- |
Mannitol Injection 20% | MANNITOL INFUS VIAL 20 % 1 | CADILA PHARMA | 100 | Injection | 213,603 | 0.08% | 23.65 | 0.24 |
-- |
| 8 |
-- |
Mannitol Injection 20% | MANNITOL SOLUT.INJ 20 % 1 | CLARIS LIFESCIENCE | 100 | Injection | 25,041,093 | 9.83% | 36.80 | 0.37 |
-- |
| 9 |
-- |
Mannitol Injection 20% | MANNITOL SOLUT.INJ 20 % 3 | CLARIS LIFESCIENCE | 350 | Injection | 149,100 | 0.06% | 90.00 | 0.26 |
-- |
| 10 |
-- |
Mannitol Injection 20% | MANNITOL INFUS VIAL 20 % | FRESENIUS KABI | 100 | Injection | 8,471,004 | 3.33% | 73.36 | 0.73 |
-- |
| 11 |
-- |
Mannitol Injection 20% | MANNITOL INFUS VIAL 20 % | FRESENIUS KABI | 350 | Injection | 1,936,096 | 0.76% | 106.94 | 0.31 |
-- |
| 12 |
-- |
Mannitol Injection 20% | MANNITOL SOLUT.INJ 20 % 1 | KRISHNAKESHAV LAB | 100 | Injection | 2,830,331 | 1.11% | 52.00 | 0.52 |
-- |
| 13 |
-- |
Mannitol Injection 20% | MANNITOL SOLUT.INJ 20 % 3 | KRISHNAKESHAV LAB | 350 | Injection | 553,148 | 0.22% | 125.00 | 0.36 |
-- |
| 14 |
-- |
Mannitol Injection 20% | MANILUP INFUS BAG 20 % 10 | LUPIN LIMITED | 100 | Injection | 1,626,322 | 0.64% | 65.38 | 0.65 |
-- |
| 15 |
-- |
Mannitol Injection 20% | MANNITOL INFUS VIAL 20 % 1 | PARENTERAL DRUGS | 100 | Injection | 788,377 | 0.31% | 20.00 | 0.20 |
-- |
| 16 |
-- |
Mannitol Injection 20% | MANNITOL INFUS VIAL 20 % 300 ML x 1 | PARENTERAL DRUGS | 300 | Injection | 275,236 | 0.11% | 50.00 | 0.17 |
-- |
| 17 |
-- |
Mannitol Injection 20% | MANNITOL SOLUT.INJ 20 % 100 ML x 1 | TABLETS INDIA | 100 | Injection | 2,245,000 | 0.88% | 53.80 | 0.54 |
-- |
| 18 |
-- |
Mannitol Injection 20% | Manniton Sol Inj 20% 100 ML | Nirma Limited | 100 | Injection | 115,488,445 | 45.34% | 67.94 | 0.68 |
-- |
| 19 |
-- |
Mannitol Injection 20% | Manniton Inj 20% 350 ML FFS | Nirma Limited | 350 | Injection | 19,173,129 | 7.53% | 138.59 | 0.40 |
-- |
| 20 |
-- |
Mannitol Injection 20% | Manniton Inj 20% 350 ML Nip | Marck Bioscience | 100 | Injection | 22,207,742 | 8.72% | 95.47 | 0.95 |
-- |
| 21 |
-- |
Mannitol Injection 20% | Manniton Inj 20% 350 ML Nip | Marck Bioscience | 350 | Injection | 3,827,063 | 1.50% | 99.81 | 0.29 |
-- |
| 22 |
-- |
Mannitol Injection 20% | Manniton Inj 20% 100 ML Gla | Rusoma Lab | 100 | Injection | 13,671,229 | 5.37% | 100.93 | 1.01 |
-- |
| 23 |
-- |
Mannitol Injection 20% | Manniton Inj 20% 350 ML Gla | Rusoma Lab | 350 | Injection | 2,158,464 | 0.85% | 142.18 | 0.41 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
254720940 | 100.00% | Average | 0.45 | 0.52 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 1.01 | Minimum | 0.17 |
|
-- |
As per the above there are 9 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
|||||||
|
-- |
Sum of MAT value considered for price calculation | 2483.00 |
-- |
-- |
|||||||
|
-- |
Sum of PTR per unit considered for price calculation | 7.20 |
-- |
-- |
|||||||
|
-- |
Number of Packs considered | 16 |
-- |
-- |
|||||||
|
-- |
Average PTR | 0.45 |
-- |
-- |
|||||||
|
-- |
Add : 16% Retailer Margin | 0.07 |
-- |
-- |
|||||||
|
-- |
Ceiling Price (without local taxes) | 0.52 |
-- |
-- |
|||||||
|
-- |
% Reduction with compared to Highest Price | 55.45% |
-- |
-- |
|||||||
|
-- |
WPI factor @ 6.32% | 0.03 |
-- |
||||||||
|
-- |
Revised Ceiling Price (including WPI but without local taxes) |
0.55 | S.O. 3134(E) dated 10.12.2014 |
-- |
|||||||
|
-- |
-- |
-- |
-- |
Source of Data Pharma Trac (May 2012) |
-- |
||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 26.2.1.2 | Glucose Injection 10% i | ALBERT DAVID* | DEXTROSE | DEXTROSE SOLUT. | Infusion | 500 | ML | 33.05 | ###### | 13.31% | 0.07 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | ALBERT DAVID* | DEXTROSE | DEXTROSE SOLUT. | Infusion | 500 | ML | 25.97 | ###### | 45.40% | 0.05 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | CLARIS LIFESCIENCE* | DEXTROSE | DEXTROSE SOLUT. | Infusion | 250 | ML | 12.37 | 2,845 | 0.00% | 0.05 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | CLARIS LIFESCIENCE* | DEXTROSE | DEXTROSE SOLUT. | Infusion | 500 | ML | 19.30 | ###### | 19.89% | 0.04 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | CLARIS LIFESCIENCE* | DEXTROSE | DEXTROSE SOLUT. | Infusion | 1000 | ML | 27.50 | 86,845 | 0.12% | 0.03 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | BAXTER | DEXTROSE | DEXTROSE SOLUT. | Infusion | 500 | ML | 21.60 | ###### | 13.39% | 0.04 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | PARENTERAL DRUGS* | DEXTROSE | DEXTROSE INFUS | Infusion | 1000 | ML | 16.75 | 437,881 | 0.59% | 0.02 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | PARENTERAL DRUGS* | DEXTROSE | DEXTROSE INFUS | Infusion | 500 | ML | 9.25 | ###### | 4.52% | 0.02 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | FRESENIUS KABI* | DEXTROSE | DEXTROSE INFUS | Infusion | 500 | ML | 19.60 | ###### | 1.47% | 0.04 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | FRESENIUS KABI* | DEXTROSE | DEXTROSE INFUS | Infusion | 1000 | ML | 18.25 | 267,016 | 0.36% | 0.02 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | KRISHNAKESHAV LAB* | DEXTROSE | DEXTROSE SOLUT. | Infusion | 100 | ML | 19.18 | 211 | 0.00% | 0.19 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | KRISHNAKESHAV LAB* | DEXTROSE | DEXTROSE SOLUT. | Infusion | 500 | ML | 17.00 | 465,037 | 0.63% | 0.03 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | WOCKHARDT LTD | DEXTROSE | DEXTROSE INFUS | Infusion | 500 | ML | 10.11 | 131,491 | 0.18% | 0.02 | -- |
| -- | 26.2.1.2 | Glucose Injection 10% isotonic | MOUNT METTUR | DEXTROSE | DEXTROSE SOLUT. | Infusion | 500 | ML | 24.00 | 104,400 | 0.14% | 0.05 | -- |
| -- |
-- |
-- | ##### | ##### | 0.04 | 0.04 | |||||||
| -- |
-- |
-- | maximum | 0.07 | minimum | 0.02 | |||||||
| -- |
-- |
-- | -- | -- | -- | -- | |||||||
| -- | -- | Sum of MAT value considered for price calculation | 735.17 | (Rs. In Lakhs) | -- | -- | -- | -- | -- | -- | |||
| -- | -- | Sum of PTR per unit considered for price calculation | 0.37 | -- |
-- |
-- | -- | -- | -- | -- | |||
| -- | -- | Number of Packs considered | -- | 10.00 | -- |
-- |
-- | -- | -- | -- | -- | ||
| -- | -- | Average PTR | -- | -- | 0.04 | -- |
-- |
-- | -- | -- | -- | -- | |
| -- | -- | Add : 16% Retailer Margin | -- | 0.01 | -- |
-- |
-- | -- | -- | -- | -- | ||
| -- | -- | Ceiling Price (without local taxes) | -- | 0.05 | -- |
-- |
-- | -- | -- | -- | -- | ||
| -- | -- |
-- |
-- | -- |
-- |
-- | -- | -- | -- | -- | -- | ||
| -- | -- | WPI @ 6.32% | (upto 5 decimals) | -- | 0.00316 | -- |
-- |
-- | -- | -- | -- | -- | |
|
-- |
Ceiling price with WPI |
-- |
0.05316 | S.O. 3131(E) dated 10.12.2014 | |||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size(In ml) | Unit | MAT Value as on Sep, 2013 | MAT % | PTR | Price per Unit | Ceiling price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 26.2.1.1 | 5 % Dextrose Injection | -- | -- | Ahlcon Parenteral | 500 Ml | 500 | Injection | 86289410 | 7.00% | 22.14 | 0.04 | -- |
| -- | -- | -- | -- | -- | B Barun Medical ( | 500 Ml | 500 | Injection | 28434956 | 2.31% | 22.14 | 0.04 | -- |
| -- | -- | -- | PVC Bag with two ports one port for extramedication and other for infusion | -- | Baxter (India) Ltd. | 500 Ml | 500 | Injection | 15652641 | 1.27% | 25.00 | 0.05 | -- |
| -- | -- | -- | Plastic Bottles Nipple Head | -- | Baxter (India) Ltd. | 500 Ml | 500 | Injection | 156838587 | 12.72% | 19.68 | 0.04 | -- |
| -- | -- | -- | Nipple Head Plastic | -- | Amanta Healthcar | 250 Ml | 250 | Injection | 90079 | 0.01% | 16.31 | 0.07 | -- |
| -- | -- | -- | Nipple Head Plastic | -- | Amanta Healthcare | 500 Ml | 500 | Injection | 82137167 | 6.66% | 23.73 | 0.05 | -- |
| -- | -- | -- | Nipple Head Plastic | -- | Amanta Healthcare | 1000 Ml | 1000 | Injection | 6974164 | 0.57% | 40.33 | 0.04 | -- |
| -- | -- | -- | -- | -- | Hindustan Antibioti | 500 ml | 500 | Injection | 176832 | 0.01% | 13.14 | 0.03 | -- |
| -- | -- | -- | Dextrose Injection I.P 5 % W/v 500 ML | -- | Parenteral Drugs | 500 Ml | 500 | Injection | 122297721 | 9.92% | 19.95 | 0.04 | -- |
| -- | -- | -- | Dextrose Injection I.P 5 % W/v 1000 ML | -- | Parenteral Drugs (I | 1000 Ml | 1000 | Injection | 11796021 | 0.96% | 33.90 | 0.03 | -- |
| -- | -- | -- | Dextrose Injection I.P 5 % W/v SD | -- | Nirma Limited | 100 ml | 100 | Injection | 144662 | 0.01% | 11.70 | 0.12 | -- |
| -- | -- | -- | -- | -- | Nirma Limited | 250 ml | 250 | Injection | 6143596 | 0.50% | 16.15 | 0.06 | -- |
| -- | -- | -- | -- | -- | Nirma Limited | 500 ml | 500 | Injection | 329418405 | 26.72% | 21.89 | 0.04 | -- |
| -- | -- | Glucose Injection 5% isotonic | -- | -- | Nirma Limited | 1000 ml | 1000 | Injection | 18150259 | 1.47% | 37.20 | 0.04 | -- |
| -- | -- | -- | Plastic Bottle | -- | Fresenius Kabi India Pvt. Ltd | 1000 ml | 1000 | Injection | 3279271 | 0.27% | 35.30 | 0.04 | -- |
| -- | -- | -- | Plastic Bottle | -- | Fresenius Kabi India Pvt. Ltd | 500 ml | 500 | Injection | 66430200 | 5.39% | 22.34 | 0.04 | -- |
| -- | -- | -- | Freeflex Glucose Injection 5 % isotonic | -- | Fresenius Kabi India Pvt. Ltd | 500 ml | 500 | Injection | 3747189 | 0.30% | 25.00 | 0.05 | -- |
| -- | -- | -- | Poly | -- | Albert David Limited | 500 ml | 500 | Injection | 98821893 | 8.02% | 21.14 | 0.04 | -- |
| -- | -- | -- | Glass | -- | Albert David Limited | 500 ml | 500 | Injection | 10146339 | 0.82% | 24.48 | 0.05 | -- |
| -- | -- | -- | Nipple Head Plastic Bottle | -- | Claris Lifesciences Limited | 250 ml | 250 | Injection | 985868 | 0.08% | 17.87 | 0.07 | -- |
| -- | -- | -- | Nipple Head Plastic Bottle | -- | Claris Lifesciences Limited | 500 ml | 500 | Injection | 167617246 | 13.60% | 23.61 | 0.05 | -- |
| -- | -- | -- | Nipple Head Plastic Bottle | -- | Claris Lifesciences Limited | 1000 ml | 1000 | Injection | 11101888 | 0.90% | 40.11 | 0.04 | -- |
| -- | -- | -- | Non PVC Bag | -- | Claris Lifesciences Limited | 500 ml | 500 | Injection | 6238131 | 0.51% | 56.05 | 0.11 | -- |
| -- | -- | -- | Dextrose Anhydrous 5 gm/100 ml | -- | IVES Drugs(India) Pvt. Ltd. | 500 ml | 500 | IV fluid | 4922013 | 0.40% | 24.99 | 0.05 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | ######### | 100.00% | -- | 0.05 | 0.06 |
| -- | -- |
-- |
-- |
-- |
-- | Maximu | 0.12 | Minimum | 0.03 | ||||
| -- | -- |
-- |
-- |
-- |
-- | -- | -- | -- | -- | ||||
| -- | -- | -- | As per the above there are 9 companies consisting of Market Share of 1% & Above | -- | -- | -- | -- | -- | -- | -- | |||
| -- | -- | -- | Sum of MAT value considered for price calculation | -- | -- | 12327.36 | (Rs. In Lakh) | -- | -- | -- | -- | ||
| -- | -- | -- | Sum of PTR per unit considered for price calculation | -- | -- | 1.15000 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | Number of Packs considered | -- | -- | 22 | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | Average PTR | -- | -- | -- | 0.05227 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Add : 16% Retailer Margin | -- | -- | -- | 0.00836 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Ceiling Price | -- | -- | -- | 0.06063 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | % Reduction with compared to Highest Price | -- | -- | 58.33% | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | WPI factor @ 6.32% | -- | -- | -- | 0.00383 | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | Revised Ceiling Price (including WPI but without local taxes) |
-- | -- | -- | 0.06446 | S.O. 3127(E) dated 10.12.2014 | -- | -- | -- | ||
|
-- |
-- | Source of Data-Companies (April 2013) |
-- |
||||||||||
| S.No. | Composition of the Prod | Brand Name | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per tablet | Ceiling Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cilnidipine and Metoprolol Succinate (ER) Tablets Each Film Coated bilayered tablet contains: Cilnidipine 10 mg Metoprolol Succinate USP eq. to Metoprolol Tartrate 50 mg (In extended release form) |
Cilacar M | J.B. Chemicals & Pharmaceuticals Limited | Tablet | 10 | 60.19 | 5,185,308 | 75.08% | 6.02 |
-- |
| 2 | Cilnipar M 50mg 10 T Each Film Coated tablet contains: Metoprolol Succinate (eq. to Metoprolol Tartrate) In extended release form 50 mg Cilnidipine IH 10 mg Excipients q.s Colour :Approved colour used |
Celnipar M | Wockhardt Limited | Tablet | 10 | 68.57 | 285,937 | 4.14% | 6.86 |
-- |
| 3 | Each film coated bilayered tablet contains: Cilnidipine 10 mg, Metoprolol Tartrated 50 mg |
Cilamet-XL | Ajanta Pharma Limited | Tablet | 10 | 69.29 | 1,435,571 | 20.78% | 6.93 |
-- |
|
-- |
-- |
-- |
-- |
-- |
6,906,816 | 100.00% | 6.60 | 7.66 | ||
|
-- |
-- |
-- |
Maximum | 6.93 | Minimum | 6.02 | ||||
|
-- |
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
-- |
||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
-- |
69.07 | (Rs. in Lakhs) |
-- |
-- |
|||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
19.81 |
-- |
-- |
-- |
||||
|
-- |
Number of Packs considered |
-- |
-- |
3 |
-- |
-- |
-- |
|||
|
-- |
Ceiling Price |
-- |
-- |
-- |
6.60 |
-- |
-- |
-- |
||
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
1.06 |
-- |
-- |
-- |
|||
|
-- |
MRP (without local taxes) |
-- |
-- |
7.66 | S.O. 3137(E) dated 10.12.2014 |
-- |
||||
|
-- |
% Reduction with compared to Highest Price |
-- |
-- |
4.76% |
-- |
-- |
-- |
|||
|
-- |
-- |
-- |
-- |
Source of Data – IMS (Jan, 2014) |
-- |
|||||
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per tablet | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|
|
-- |
AZITHROMYCIN+LEVOFL |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | ERTYCIN-L FILM C.TABS 2 |
-- |
ABBOTT HEALTHCARE | Tablet | 6 | 64.69 | 14,548,063 | 15.97% | 10.78 |
-- |
| 2 | AZIFINE-L FILM C.TABS 25 |
-- |
GLENMARK PHARMA | Tablet | 10 | 107.70 | 25,183,584 | 27.65% | 10.77 |
-- |
| 3 | QULEF-Z FILM C.TABS 25 |
-- |
HETERO HEALTHCARE | Tablet | 5 | 45.43 | 8,809,427 | 9.67% | 9.09 |
-- |
| 4 | LEVOMAC-AZ FILM C.TAB |
-- |
MACLEODS PHARMA | Tablet | 5 | 53.34 | 10,831,640 | 11.89% | 10.67 |
-- |
| 5 | ZITHROX-LX FILM C.TABS |
-- |
MACLEODS PHARMA | Tablet | 5 | 53.34 | 10,581,035 | 11.62% | 10.67 |
-- |
| 6 | XUV FILM C.TABS 250 MG |
-- |
MEDLEY PHARMA | Tablet | 5 | 53.34 | 2,544,956 | 2.79% | 10.67 |
-- |
| 7 | LOXOF-AZ FILM C.TABS 2 |
-- |
RANBAXY | Tablet | 10 | 106.67 | 18,582,769 | 20.40% | 10.67 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
91,081,474 | 100.00% | 10.47 | 12.15 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 10.78 | Minimum | 9.09 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||||
|
-- |
As per the above there are 6 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
|||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
910.81 | (Rs. in Lakhs) |
-- |
-- |
||||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
73.32 |
-- |
-- |
|||||
|
-- |
Number of Packs considered |
-- |
-- |
-- |
7 |
-- |
-- |
|||
|
-- |
Retail Price |
-- |
10.47 |
-- |
-- |
|||||
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
-- |
1.68 |
-- |
-- |
|||
|
-- |
MRP (without local taxes) |
-- |
-- |
-- |
12.15 | S.O. 3139(E) dated 10.12.2014 |
-- |
|||
|
-- |
% Reduction with compared to Highest Price |
-- |
2.88% |
-- |
-- |
|||||
|
-- |
-- |
-- |
-- |
|||||||
|
-- |
-- |
-- |
-- |
Source of Data – IMS (Jan, 2014) |
-- |
|||||
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per tablet | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|
|
-- |
AZITHROMYCIN+LEVOFL |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | ERTYCIN-L FILM C.TABS 5 |
-- |
ABBOTT HEALTHCARE | Tablet | 6 | 113.52 | 26,054,659 | 18.70% | 18.92 |
-- |
| 2 | AZIFINE-L FILM C.TABS 50 |
-- |
GLENMARK PHARMA | Tablet | 5 | 96.15 | 13,545,029 | 9.72% | 19.23 |
-- |
| 3 | QULEF-Z FILM C.TABS 50 |
-- |
HETERO HEALTHCARE | Tablet | 5 | 76.23 | 8,255,797 | 5.92% | 15.25 |
-- |
| 4 | ATM-LX FILM C.TABS 500 |
-- |
INDOCO | Tablet | 5 | 106.67 | 4,924,798 | 3.53% | 21.33 |
-- |
| 5 | LEVOMAC-AZ FILM C.TAB |
-- |
MACLEODS PHARMA | Tablet | 5 | 91.43 | 48,512,950 | 34.81% | 18.29 |
-- |
| 6 | ZITHROX-LX FILM C.TABS |
-- |
MACLEODS PHARMA | Tablet | 5 | 91.41 | 14,415,550 | 10.34% | 18.28 |
-- |
| 7 | XUV FILM C.TABS 500 MG |
-- |
MEDLEY PHARMA | Tablet | 5 | 91.43 | 8,181,524 | 5.87% | 18.29 |
-- |
| 8 | LOXOF-AZ FILM C.TABS 5 |
-- |
RANBAXY | Tablet | 5 | 95.24 | 15,473,977 | 11.10% | 19.05 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
139,364,284 | 100.00% | 18.58 | 21.55 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 21.33 | Minimum | 15.25 |
|
-- |
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
As per the above there are 7 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
|||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
1393.64 | (Rs. in Lakhs) |
-- |
-- |
||||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
148.64 |
-- |
-- |
|||||
|
-- |
Number of Packs considered |
-- |
-- |
-- |
8 |
-- |
-- |
|||
|
-- |
Retail Price |
-- |
-- |
-- |
18.58 |
-- |
-- |
|||
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
-- |
2.97 |
-- |
-- |
|||
|
-- |
MRP (without local taxes) |
-- |
-- |
-- |
21.55 | S.O. 3139(E) dated 10.12.2014 |
-- |
|||
|
-- |
% Reduction with compared to Highest Price |
-- |
12.89% |
-- |
-- |
|||||
|
-- |
-- |
-- |
-- |
-- |
Source of Data-Company/Pharma Trac data May, 2013 |
-- |
-- |
-- |
-- |
-- |
| S.No. | Composition of the | Brand Name | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per ml | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Gatifloxacin, Prednisolone and Benzalkonium Chloride Eye Drops Each ml contains: Gatifloxacin IP Eq. to Gatifloxacin(Anhydrous)- 3.0 mg Prednisolone Acetate IP- 10.0 mg Benzalkonium Chloride IP-0.006% w/v (as preservative) Sterile aqueous Vehicle q.s |
GATIQUIN P | Cipla Ltd. | Eye Drops | 10 | 21.30 | 37,493,607 | 36.60% | 2.13 |
-- |
|
-- |
GATIQUIN P | Cipla Ltd. | Eye Drops | 5 | 10.65 | 15,243,352 | 14.88% | 2.13 |
-- |
|
|
-- |
Z PRED | Allergan India Ltd. | Eye Drops | 5 | 10.65 | 48,669 | 0.05% | 2.13 |
-- |
|
|
-- |
GATIQUIN P | Aditi Pharmaceuticals pvt. Ltd. | Eye Drops | 10 | 21.30 | 49,664,458 | 48.48% | 2.13 |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
102,450,085 | 100.00% | 2.13 | 2.47 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 2.13 | Minimum | 2.13 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
As per the above there a |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Sum of MAT value consi |
-- |
-- |
-- |
-- |
1024.01 | (Rs. in Lakhs) |
-- |
-- |
-- |
|
-- |
Sum of PTR per unit con |
-- |
-- |
-- |
-- |
6.39 |
-- |
-- |
-- |
-- |
|
-- |
Number of Packs consid |
-- |
-- |
-- |
-- |
3 |
-- |
-- |
-- |
-- |
|
-- |
Retail Price |
-- |
-- |
-- |
-- |
2.13 |
-- |
-- |
-- |
-- |
|
-- |
Add : 16% Retailer Margi |
-- |
-- |
-- |
-- |
0.34 |
-- |
-- |
-- |
-- |
|
-- |
MRP (without local taxes) |
-- |
-- |
-- |
-- |
2.47 | S.O. 3140(E) da |
-- |
-- |
-- |
|
-- |
% Reduction with compa |
-- |
-- |
-- |
-- |
0.00% |
-- |
-- |
-- |
|
|
-- |
Source of Data-Pharma Trac | |||||||||
| S.No. | Composition of the formula | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per tablet | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GLYCINORM M OD 60/500 M | IPCA LABORATORIES PVT LT | Tablet | 10 | 53.34 | 39795587 | 48.08% | 5.33 |
-- |
| 2 | DIANORM M OD 60/500 MG | MICRO LABS LTD | Tablet | 10 | 61.60 | 23939025 | 28.92% | 6.16 |
-- |
| 3 | RECLIMET OD 60/500 MG T | DR. REDDYS LABORATORIE | Tablet | 15 | 71.60 | 10943367 | 13.22% | 4.77 |
-- |
| 4 | GLIZID M OD 60/500 MG TAB | PANACEA BIOTEC LTD | Tablet | 10 | 65.37 | 7829122 | 9.46% | 6.54 |
-- |
| 5 | GLYCHEK M SR 60/500 MG | INDOCO REMEDIES LTD | Tablet | 10 | 29.64 | 263055 | 0.32% | 2.96 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
82770159 | 100.00% | 5.70 | 6.61 |
|
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 6.54 | Minimum | 4.77 |
|
-- |
-- |
||||||||
|
-- |
As per the above there are 4 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
|||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
825.07 | Rs. In lakhs |
-- |
-- |
-- |
||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
22.80 |
-- |
-- |
||||
|
-- |
Number of Packs considered |
-- |
4 |
-- |
-- |
||||
|
-- |
Ceiling Price |
-- |
-- |
5.70 |
-- |
-- |
|||
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
0.91 |
-- |
-- |
|||
|
-- |
MRP (without local taxes) |
-- |
-- |
6.61 | S.O. 3142(E) dated 10.12.2014 |
-- |
|||
|
-- |
% Reduction with compared to Highest Price |
-- |
12.84% |
-- |
-- |
||||
| Data Source- Companies (November’2013) |
-- |
-- |
-- |
-- |
|||||
| Unique No. | Composition of the Product | Brands | Company | Strenght | Pack size | MAT Value as on Nov’2013 | MAT % | Price to Retailer (Rs.) | Price per Unit | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|
| 13.1.6.2 & 15.1.8.1 | Zuvendine OZ Ointment (Povidone Iodine IP 5% w/w (available Iodine 0.5% w/w) Ornidazole IP 1% w/w In an ointment base Q.S. |
Ecoseptic-OZ | Helios Pharmaceuticals | 15 gm | 15 | 890,373 | 15.08% | 40.00 | 2.67 |
-- |
|
-- |
Qugyl-OP | RPG Life Sciences Limited | 15 gm | 15 | 2,000,000 | 33.87% | 37.73 | 2.52 |
-- |
|
|
-- |
Megatrum | Group Pharmaceuticals Ltd. | 15 gm | 15 | 3,014,088 | 51.05% | 38.50 | 2.57 |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
5,904,461 | 100.00% | Average | 2.59 | 3.00 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 2.67 | Minimum | 2.52 |
|
-- |
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
||||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
59.04 | (Rs. In Lakhs) |
-- |
-- |
||||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
7.76 |
-- |
-- |
-- |
||||
|
-- |
Number of Packs considered |
-- |
3 |
-- |
-- |
-- |
||||
|
-- |
Retail Price |
-- |
-- |
2.59 |
-- |
-- |
-- |
|||
|
-- |
Add : 16% Retailer Margin |
-- |
0.41 |
-- |
-- |
-- |
||||
|
-- |
MRP (without local taxes) |
-- |
3.00 | S.O. 3144(E) dated 10.12.2014 |
-- |
-- |
||||
|
-- |
% Reduction with compared to Highest Price |
-- |
3.00% |
-- |
-- |
-- |
||||
| Source of Data Pharma Trac and companies (Jan. 2014) | ||||||||||
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per tablet | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TELPRES AMH 40/5/12.5 MG | ABBOTT HEALTHCARE P | Tablet | 10 | 75.35 | 5389057 | 1.47% | 7.54 |
-- |
| 2 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TELLZY AH 40/5/12.5 MG TAB | ALEMBIC LTD | Tablet | 10 | 86.74 | 17457000 | 4.77% | 8.67 |
-- |
| 3 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TETAN TRIO 40/5/12.5 MG TA | ALEMBIC LTD | Tablet | 10 | 73.92 | 3951911 | 1.08% | 7.39 |
-- |
| 4 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TELVAS 3D 40/5/12.5 MG TAB | ARISTO PHARMACEUTIC | Tablet | 10 | 46.35 | 50671900 | 13.84% | 4.64 |
-- |
| 5 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | Amlosage 3D | ARISTO PHARMACEUTICA | Tablet | 7 | 32.44 | 3092200 | 0.84% | 4.63 |
-- |
| 6 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | Telsartan Trio | Dr. Reddy | Tablet | 30 | 143.98 | 13000000 | 3.55% | 4.80 |
-- |
| 7 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TELMA AMH 40/5/12.5 MG TA | GLENMARK PHARMACEU | Tablet | 10 | 75.43 | 32198000 | 8.79% | 7.54 |
-- |
| 8 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | Eritel Trio | Eris Lifesciences Pvt Ltd | Tablet | 10 | 72.38 | 20259099 | 5.53% | 7.24 |
-- |
| 9 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TELMICHEK AH 40/5/12.5 MG | INDOCO REMEDIES LTD | Tablet | 10 | 71.62 | 4194783 | 1.15% | 7.16 |
-- |
| 10 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TAH | Intas Pharmaceuticals | Tablet | 10 | 72.99 | 40800000 | 11.14% | 7.30 |
-- |
| 11 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TRIMACSART 40/5/12.5 MG T | MACLEODS PHARMACEU | Tablet | 10 | 68.57 | 16261000 | 4.44% | 6.86 |
-- |
| 12 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TELMIKIND AMH 40/5/12.5 M | MANKIND PHARMACEUTI | Tablet | 10 | 38.10 | 28000000 | 7.64% | 3.81 |
-- |
| 13 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TELMED AH 40/5/12.5 MG TA | MEDLEY PHARMACEUTI | Tablet | 10 | 68.58 | 26500000 | 7.24% | 6.86 |
-- |
| 14 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | ARBITEL AM H 40/5/12.5 MG | MICRO LABS LTD | Tablet | 10 | 73.14 | 5594821 | 1.53% | 7.31 |
-- |
| 15 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TELEACT TRIO 40/5/12.5 MG | RANBAXY LABORATORIE | Tablet | 10 | 70.86 | 12569349 | 3.43% | 7.09 |
-- |
| 16 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | TAZLOC TRIO 40/5/12.5 MG T | USV LTD | Tablet | 10 | 69.80 | 78730003 | 21.50% | 6.98 |
-- |
| 17 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | Teldey Trio | Torrent Pharma | Tablet | 10 | 75.43 | 3520000 | 0.96% | 7.54 |
-- |
| 18 | Telmisartan 40mg+Amlodipine 5mg + Hydrochlorothiazide 12.5mg | INDITEL AH 40/5/12.5 MG TA | ZYDUS CADILA | Tablet | 10 | 83.77 | 4064205 | 1.11% | 8.38 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
366,253,328 | 100.00% | 6.72 | 7.80 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 8.67 | Minimum | 3.81 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
As per the above there are 15 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Sum of MAT value considered for price calculation |
-- |
-- |
3627.33 | (Rs. in lakh) |
-- |
||||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
-- |
114.20 |
-- |
-- |
||||
|
-- |
Number of Packs considered |
-- |
-- |
17 |
-- |
-- |
||||
|
-- |
Average PTR |
-- |
-- |
6.72 |
-- |
-- |
||||
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
1.08 |
-- |
-- |
||||
|
-- |
Retail Price (without local taxes) |
-- |
-- |
7.80 | S.O. 3145(E) dated 10.12.2014 |
-- |
||||
|
-- |
% Reduction with compared to Highest Price |
-- |
-- |
22.49% |
-- |
-- |
||||
| Source of Data- Company/Pharma Trac, Jan’2013 | ||||||||||
| Unique No. as per NLEM | Name of the Product | Composition of the Product | Company | Brands | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st, Jan 2013 | MAT % | Price per Tablet | Retail Price with 16% |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.3.4.2 | Losartan Potassium 50 mg + Chlorthalidone 12.5 mg | Each tablet contains: Losartan Potassium 50mg Chlorthalidone 12.5 mg |
IPCA Laboratories Ltd. | CTDL-L | Tablets | 10 | 63.21 | 600000 | 85.71% | 6.32 |
-- |
|
-- |
-- |
-- |
INDSWIFT Laboratories Ltd. | ARBISAAR H | Tablets | 10 | 15.24 | 100000 | 14.29% | 1.52 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
700000 | 100.00% | 3.92 | 4.55 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 6.32 | Minimum | 1.52 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Sum of MAT value considered for price calculation |
-- |
7 | (Rs. in Lakhs) |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
7.84 |
-- |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Number of Packs considered |
-- |
2 |
-- |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Ceiling Price |
-- |
-- |
3.92 |
-- |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
0.63 |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
MRP (without local taxes) |
-- |
-- |
4.55 | S.O. 3146(E) dated 10.12.2014 |
-- |
-- |
-- |
-- |
||
|
-- |
% Reduction with compared to Highest Price |
-- |
37.97% |
-- |
-- |
-- |
-- |
-- |
|||
| Source of Data-IMS-Health/Companies December 2013 | |||||||||||
| S.No. | Composition of the formula | Company | Dosage Form | Pack size | MAT Units | Price to Retailer (Rs.) | MAT Value | MAT % | Price per tablet | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | THYROBEST TAB UNCOA | BESTOCHEM | Tablet | 10 | 30,210 | 6.86 | 207,238 | 0.11% | 0.69 |
-- |
| 2 | THYROFIT TAB UNCOAT | ERIS LIFE SCIENCES | Tablet | 30 | 169,421 | 21.95 | 3,718,790 | 1.98% | 0.73 |
-- |
| 3 | ELTROXIN TABS 25 Y x 60 | GLAXOSMITHKLINE | Tablet | 60 | 1,533,254 | 59.09 | 90,600,000 | 48.16% | 0.98 |
-- |
| 4 | LETHYROX TAB UNCOA | INTAS | Tablet | 100 | 40,194 | 69.29 | 2,785,072 | 1.48% | 0.69 |
-- |
| 5 | THYROUP TABS 25 Y x 10 | LUPIN LABS | Tablet | 100 | 107,474 | 106.30 | 11,424,467 | 6.07% | 1.06 |
-- |
| 6 | THYROX TAB UNCOATE | MACLEODS PHARMA | Tablet | 100 | 869,663 | 88.54 | 77,000,000 | 40.93% | 0.89 |
-- |
| 7 | THYROTOP TAB UNCOA | MICRO LABS | Tablet | 30 | 4,598 | 27.72 | 127,449 | 0.07% | 0.92 |
-- |
| 8 | THYROSURZ TAB UNCO | SANDOZ | Tablet | 100 | 2,803 | 77.08 | 216,053 | 0.11% | 0.77 |
-- |
| 9 | THYOBUILD TABS 25 Y x | TORRENT PHARMA | Tablet | 100 | 24,616 | 83.85 | 2,063,058 | 1.10% | 0.84 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
188,142,128 | 100.00% | 0.98 | 1.14 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 1.06 | Minimum | 0.89 |
|
-- |
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
||||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
1790.24 | (Rs. in Lakhs) |
-- |
|||||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
2.93 |
-- |
-- |
|||||
|
-- |
Number of Packs considered |
-- |
3 |
-- |
-- |
|||||
|
-- |
Retail Price |
-- |
-- |
0.98 |
-- |
-- |
||||
|
-- |
Add : 16% Retailer Margin |
-- |
0.16 |
-- |
-- |
|||||
|
-- |
MRP (without local taxes) |
-- |
1.14 | S.O. 3148(E) dated 10.12.2014 |
-- |
|||||
|
-- |
% Reduction with compared to Highest Price |
-- |
7.55% |
-- |
-- |
|||||
| Source of Data-IMS-Health/Companies December 2013 | ||||||||||
| S.No. | Composition of the formula | Company | Dosage Form | Pack size | MAT Units | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | THYROFIT TAB UNCOATE | ERIS LIFE SCIENCES | Tablet | 30 | 85,474 | 23.35 | 1,995,821 | 2.13% | 0.78 |
-- |
| 2 | ELTROXIN TABS 75 Y x 60 | GLAXOSMITHKLINE | Tablet | 60 | 554,042 | 66.06 | 36,600,000 | 39.03% | 1.10 |
-- |
| 3 | LETHYROX TAB UNCOAT | INTAS | Tablet | 100 | 18,802 | 83.15 | 1,563,427 | 1.67% | 0.83 |
-- |
| 4 | THYROUP TABS 75 Y x 10 | LUPIN LABS | Tablet | 100 | 58,382 | 109.75 | 6,407,399 | 6.83% | 1.10 |
-- |
| 5 | THYROX TAB UNCOATED | MACLEODS PHARMA | Tablet | 100 | 443,927 | 103.17 | 45,800,000 | 48.84% | 1.03 |
-- |
| 6 | THYOBUILD TABS 75 Y x 1 | TORRENT PHARMA | Tablet | 100 | 14,212 | 99.23 | 1,410,297 | 1.50% | 0.99 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
93,776,944 | 100.00% | 1.08 | 1.25 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 1.10 | Minimum | 1.03 |
|
-- |
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
As per the above there are 4 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
||||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
888.07 | (Rs. in Lakhs) |
-- |
|||||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
3.23 |
-- |
-- |
|||||
|
-- |
Number of Packs considered |
-- |
3 |
-- |
-- |
|||||
|
-- |
Retail Price |
-- |
-- |
1.08 |
-- |
-- |
||||
|
-- |
Add : 16% Retailer Margin |
-- |
0.17 |
-- |
-- |
|||||
|
-- |
MRP (without local taxes) |
-- |
1.25 | S.O. 3148(E) dated 10.12.2014 |
-- |
|||||
|
-- |
% Reduction with compared to Highest Price |
-- |
1.82% |
-- |
-- |
|||||
| Source of Data- Company/IMS, Jan’2014 | ||||||||||
| Unique No. as per NLEM | Name of the Product | Composition of the Product | Company | Brands | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st, Jan 2014 | MAT % | Price per unit | Retail Price with 16% |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.1.1.0 | ARVAST A 150 (Rosuvastatin 10 mg and Aspirin 150 mg capsules) |
Each hard Gelatin Capsule Contains: Rosuvastatin Calcium Eq. to Rosuvastatin 10 mg (as granules) Aspirin 150 mg (as two entric coated tablets) excipients |
Intas Pharmaceuticals Ltd. | ARVAST-A 150 10 Capsule | Capsule | 10 | 42.11 | 400000 | 1.16% | 4.21 |
-- |
|
-- |
-- |
-- |
Alkem Laboratories Limited | Jupiros-A 150 Capsule | Capsule | 10 | 34.36 | 105218 | 0.31% | 3.44 |
-- |
|
-- |
-- |
-- |
Unichem | Unistar | Capsule | 10 | 36.21 | 26617704 | 77.42% | 3.62 |
-- |
|
-- |
-- |
-- |
Sun Pharma | Rozavel A | Capsule | 10 | 39.25 | 7258268 | 21.11% | 3.93 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
34381190 | 100.00% | 3.92 | 4.55 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 4.21 | Minimum | 3.62 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Sum of MAT value considered for price calculation |
-- |
342.76 | (Rs. in Lakhs) |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
11.76 |
-- |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Number of Packs considered |
-- |
3 |
-- |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Ceiling Price |
-- |
-- |
3.92 |
-- |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
0.63 |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
MRP (without local taxes) |
-- |
-- |
4.55 | S.O. 3149(E) dated 10.12.2014 |
-- |
-- |
-- |
-- |
||
|
-- |
% Reduction with compared to Highest Price |
-- |
6.89% |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Source of Data-Company (July’ 2013) |
-- |
-- |
-- |
-- |
||||||
| S.No. | Composition of the Prod | Brand Name | Company | Dosage Form | Pack size (In gm) | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Clobetavate NM 10 gms Cream Clobetasol Propionate U.S.P 0.05% w/w Neomycin sulphate I.P equivalent to Neomycin 0.1% w/w Miconazole Nitrate I.P 2.0% w/w Cream base |
Topinova Cream | Zuventus Healthcare Limited | Cream | 10 | 26.67 | 300,000 | 104.92% | 2.67 |
|
-- |
-- |
-- |
-- |
-- |
300,000 | 104.92% | 2.67 | ||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Monopoly situation as only M/s. Zuventus is the known manufacturer |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
PTR per unit |
-- |
-- |
2.67 |
-- |
-- |
-- |
-- |
-- |
|
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Section: 13 –Dermatological medicines (Topical) |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
13.1: Antifungal medicines |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
|
-- |
Miconazole | P,S,T | Cream | 2% | 1.39 | 3rd | 1,904 | 28.06.2013 | 33.23% |
|
-- |
-- |
-- |
-- |
Average Reduction | 33.23% | ||||
|
-- |
Therefore, PTR per unit |
-- |
2.67x(1-33.23%) |
-- |
1.78 |
-- |
-- |
-- |
|
|
-- |
Add: 16% Retailer Margin |
-- |
-- |
0.28 |
-- |
-- |
-- |
||
|
-- |
Retail Price per unit |
-- |
-- |
2.06 | S.O. 3150(E) dated 10.12.2014 |
-- |
-- |
||
| Source of Data-Pharma Trac (Feb, 2014) |
-- |
-- |
-- |
||||||
| S.No. | Composition of the | Pack Description | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per capsule |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Chekcid-D SR Capsules Each hard gelatin capsule contains: Ilaprazole 10 mg(as entric coated tablet) Domperidone 30 mg(as film coated sustained release tablet) |
ILADOM 30/10 MG CAPSULE 1 | AJANTA PHARMA LTD | Capsule | 10 | 76.22 | 3,309,091 | 1157.28% | 7.62 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
3,309,091 | 1157.28% | 7.62 |
|
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
Monopoly situation as only M/s. Ajanta Pharma ltd. is the known manufacturer |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
PTR per unit |
-- |
-- |
7.62 |
-- |
-- |
-- |
-- |
|
|
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Section 17.2: Antiemetics |
-- |
-- |
-- |
|||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
| 1 | Domperidone | P,S, T | Tablet | 10 mg | 2.26 | 4th | 2063 | 05.07.2013 | 46.32% |
| 2 | Domperidone | P,S, T | Syrup | 1 mg/ml | 1.03 | 1st | 1654 | 14.06.2013 | 54.71% |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Average Reduction | 50.52% | |
|
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
Therefore, PTR per unit | 7.62x(1-50.52%) | 3.77 |
-- |
-- |
-- |
|||
|
-- |
Add: 16% Retailer Margin |
-- |
0.60 |
-- |
-- |
-- |
|||
|
-- |
Retail Price per unit |
-- |
4.37 | S.O. 3151(E) dated 10.12.2014 |
-- |
-- |
|||
| Source of Data-Company (Dec’ 2013) |
-- |
-- |
-- |
||||||
| S.No. | Composition of the Prod | Brand Name | Company | Dosage Form | Pack size(In ml) | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Cyclosporine Eye Drops 0.05% w/v IFLO Each ml contains: Cyclosporine USP 0.5mg Benzalkonium Chloride 0.01% w/v (as preservative) |
Restasis | Allergan India Private Limited | Drop | 4 | 442.86 | 55983672 | 100% | 110.72 |
|
-- |
Restasis | Allergan India Private Limited | Drop | 12 | 1,339.43 | 111.62 | |||
|
-- |
-- |
-- |
-- |
-- |
-- |
Average | 111.17 | ||
|
-- |
Monopoly situation as only M/s. Allergan is the known manufacturer |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
PTR per unit |
-- |
-- |
111.17 |
-- |
-- |
-- |
-- |
-- |
|
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Section: 8 – Antineoplastic, immunosuppressives and medicines used in palliative care |
-- |
-- |
-- |
-- |
||||
|
-- |
8.1: Immunosuppressive medicines |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
|
-- |
Cyclosporine | T | Capsules | 25 mg | 24.75 | 1st | 1602 | 14.06.2013 | 27.91% |
|
-- |
Cyclosporine | T | Capsules | 50 mg | 48.26 | 1st | 1603 | 14.06.2013 | 29.63% |
|
-- |
Cyclosporine | T | Capsules | 100 mg | 106.29 | 3rd | 1889 | 28.06.2013 | 37.77% |
|
-- |
Cyclosporine | T | Concentrate for Injection | 100 mg/ml | 118.64 | 8th | 3333 | 05.11.2013 | 29.42% |
|
-- |
-- |
-- |
Average Reduction | 31.18% | |||||
|
-- |
Therefore, PTR per unit |
-- |
111.17x(1-31.18%) |
-- |
76.51 |
-- |
-- |
-- |
|
|
-- |
Add: 16% Retailer Margin |
-- |
-- |
12.24 |
-- |
-- |
-- |
||
|
-- |
Retail Price per ml |
-- |
-- |
88.75 |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Retail Price per 3 ml |
-- |
-- |
-- |
266.25 | S.O. 3152(E) dated 10.12.2014 |
-- |
-- |
|
| Source of Data- Company, Oct’ 2013 |
-- |
-- |
|||||||
| Unique No. as per NLEM | Name of the Product | Composition of the Product | Company | Brands | Dosage Form | Pack Size | Price to Retailer | MAT Value as on Oct, 2013 | MAT % | Price per Tablet |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.1.2.1 | Diclofenac Potassium and Serratiopeptidase Tablets | Each film coated tablet contains: Diclofenac Potassium – 50mg Serratiopeptidase – 15mg (30,000 units of Serratiopeptidase) (As enteric coated granuals) |
Biomax Biotechnics Pvt. Ltd. | SIDER -K 15 | Tablets | 10 | 49.1 | 883800 | 100 | 4.91 |
|
-- |
Monopoly situation as only |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
PTR per unit |
-- |
-- |
4.91 |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Price fixed in the relevant |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Section: 2 – Analgesics , Antipyretics, Nonsteroidal Anti-inflammatory Medicines, Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders |
-- |
-- |
-- |
-- |
|||||
|
-- |
2.1: Non-Opioid Analgesics, Antipyretics and Nonsteroidal Anti-inflammatory Medicines |
-- |
-- |
-- |
-- |
|||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | Diclofenac | T | Tablets | 50 mg | 1.95 | 3rd | 1909(E) | 28.06.2013 | 52.64 |
-- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Average Reduction | 52.64 |
-- |
|
|
-- |
Therefore, PTR per unit | 4.91x(1-52.64%) | 2.33 |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Add: 16% Retailer Margin |
-- |
0.37 |
-- |
-- |
-- |
-- |
-- |
||
|
-- |
Retail Price per unit |
-- |
2.70 | S.O. 3153(E) d |
-- |
-- |
-- |
-- |
||
| Source of Data-Company (July, 2013) |
-- |
-- |
-- |
|||||||
| S.No. | Composition of the | Pack Description | Company | Dosage Form | Pack size(In gm) | Price to Retailer (Rs.) | MAT Value | MAT % | Price per gm |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Clobetavate GM 10gm Clobetasol propionate 0.05% w/w Neomycin sulphate eq. to Neomycin 0.5% Micronaozle Nitrate 2.0% w/w Zinc sulphate 2.0% |
Clogra-BG Cream | GRAF Laboratories Pvt. Ltd. | Cream | 10 | 22.86 | 365,092 | 127.68% | 2.29 |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
365,092 | 127.68% | 2.29 |
|
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
Monopoly situation as only M/s. GRAF Laboratories Pvt. Ltd. is the known manufacturer |
-- |
-- |
-- |
-- |
||||
|
-- |
PTR per unit |
-- |
-- |
2.29 |
-- |
-- |
-- |
-- |
|
|
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
Section 13-Dermatological medicines (Topical) |
-- |
-- |
-- |
|||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
| 1 | Miconazole | P,S, T | Cream | 2% | 1.39 | 3rd | 1904 | 28.06.2013 | 33.23% |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Average Reduction | 33.23% | |
|
-- |
-- |
-- |
-- |
-- |
|||||
|
-- |
Therefore, PTR per unit | 2.29x(1-33.23%) | 1.53 |
-- |
-- |
-- |
|||
|
-- |
Add: 16% Retailer Margin |
-- |
0.24 |
-- |
-- |
-- |
|||
|
-- |
Retail Price per unit |
-- |
1.77 | S.O. 3154(E) dated 10.12.2014 |
-- |
-- |
|||
| Source of Data company (September 2013) |
-- |
-- |
-- |
||||||
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size (tablet) | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | Calcium carbonate 200mg+ | Becotrol 10 caps | Pfizer | Tablet | 10 | 102.41 | 31,065,000 | 2163.95% | 10.24 |
|
-- |
Mecobalamin 1500 mcg + F | Calcium carbonate 200mg+ c |
-- |
-- |
-- |
-- |
31,065,000 | 2163.95% | 10.24 |
|
-- |
Pyridoxine Hcl 3 mg | Mecobalamin 1500 mcg + Foli |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Vitamin B6 Ip-3 mg |
-- |
-- |
-- |
-- |
||||
|
-- |
Monopoly situation as only M/s. Pfizer is the known manufacturer |
-- |
-- |
-- |
-- |
-- |
|||
|
-- |
PTR per unit |
-- |
10.24 |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: |
-- |
-- |
-- |
-- |
||||
|
-- |
Section: 27.2, 10.1.3 and 10.1.5 |
-- |
-- |
-- |
-- |
-- |
|||
| NLEM | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
| 27.2 | Calcium carbonate | PST | Tablets | 250 mg | 1.68 | 7th | 2867(E) | 20.09.13 | 18.45% |
| 27.2 | Calcium carbonate | PST | Tablets | 500 mg | 1.67 | 5th | 2255 | 22.07.2013 | 24.33% |
| 10.1.3 | Folic Acid | PST | Tablets | 1 mg | 0.25 | 8th | 3365 | 05.11.2013 | 48.07% |
| 10.1.3 | Folic Acid | PST | Tablets | 5 mg | 1.37 | 9th | 3570(E) | 02.12.2013 | 38.02% |
| 10.1.5 | Pyridoxine | PST | Tablets | 10 mg | 0.21 | 17th | 2091 | 20.08.2014 | 47.85% |
|
-- |
-- |
-- |
-- |
Average Reduction | 35.34% | ||||
|
-- |
Therefore, PTR per unit |
-- |
10.24x(1-35.34%) |
-- |
6.62 |
-- |
-- |
-- |
|
|
-- |
Add : 16% Retailer Margin |
-- |
1.06 |
-- |
-- |
-- |
|||
|
-- |
Retail Price (without local taxes) |
-- |
7.68 | S.O. 3155(E) dated 10.12.2014 |
-- |
-- |
|||
|
-- |
% Reduction with compared to Highest Price |
-- |
35.34% |
-- |
-- |
-- |
|||
Last Page Updated: 02-02-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)